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ABSTRACTS 
 
This thesis encompasses two literature reviews (chapter 2 & 3) and two experimental 
chapters (4 and 5) examining the available literature on exercise and cancer, 
resistance training and its anabolic responses in older men and women, the side 
effects of Androgen Deprivation Therapy (ADT) for prostate cancer and finally, the 
role of resistance exercise as a clinical intervention to counteract such changes as an 
adjuvant therapy. 
REVIEW OF LITERATURE ONE  
A REVIEW OF EXERCISE INTERVENTION STUDIES 
UNDERTAKEN IN CANCER PATIENTS 
 
Purpose: To present an overview of exercise interventions in cancer patients during 
and after treatment and evaluate a dose training response considering type, 
frequency, volume and intensity of training along with their expected physiological 
outcomes. 
Methods: The review is divided into studies that incorporated cardiovascular 
training, combination of cardiovascular, resistance and flexibility training and 
resistance training alone during and after cancer management. The criteria for 
inclusion were based on studies sourced from electronic and non-electronic databases 
and which incorporated pre- and post-intervention assessment with statistical 
analysis of the data.  
Results: Twenty-six published studies are summarized. The majority of the studies 
demonstrate physiological and psychological benefits. However, most of these 
studies suffer limitations because they are not randomized controlled trials and/or use 
small sample sizes. Predominantly, studies have been conducted with breast cancer 
patients using cardiovascular training rather than resistance exercise as the exercise 
modality. Recent evidence supports the use of resistance exercise or “anabolic 
exercise” during cancer management as an exercise mode to counteract the side 
effects of the disease and treatment.  
  iv
Conclusion: Evidence underlines preliminary positive physiological and 
psychological benefits from exercise when undertaken during or after traditional 
cancer treatment. As such, other cancer groups in addition to breast cancer should 
also be included in clinical trials to address more specifically dose response training 
for this population. Contemporary resistance training designs which provide a strong 
anabolic effect for muscle and bone may have an impact on counteracting some of 
the side effects of cancer management assisting patients to improve physical function 
and quality of life.   
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 REVIEW OF LITERATURE TWO 
ANABOLIC RESPONSES TO RESISTANCE TRAINING IN 
OLDER MEN AND WOMEN: A BRIEF REVIEW 
 
Resistance training has been shown to be the most effective exercise mode to induce 
anabolic adaptations in older men and women. Advances in imaging techniques and 
histochemistry have increased the ability to detect such changes confirming the high 
level of adaptability that remains in aging skeletal muscle. This brief review presents 
a summary of the resistance training studies which directly compare chronic anabolic 
responses to training in older (> 60 years) men and women. Sixteen studies are 
summarized; the majority of these studies indicate similar relative anabolic responses 
between older men and women following resistance training. Relatively small 
sample sizes in most of the interventions limited the ability to detect significant sex 
differences and should be considered when interpreting these studies. Future research 
should incorporate larger sample sizes with multiple measurement time points for 
anabolic responses. 
 
  vi
 EXPERIMENTAL STUDY ONE 
CHANGES IN MUSCLE, FAT, AND BONE MASS AFTER 36 
WEEKS OF MAXIMAL ANDROGEN BLOCKAGE FOR 
PROSTATE CANCER 
 
Objective: To assess the effects of androgen deprivation therapy (ADT) on whole 
body and regional muscle, fat and bone mass in men with prostate cancer without 
metastatic disease.  
Patients and methods: Seventy-two men aged 44 to 88 years underwent spine, hip 
and whole body dual-energy X-ray absorptiometry (DXA) scans at baseline and 
following 36 weeks of ADT. Change in whole body and regional lean mass (LM), fat 
mass (FM), and bone mineral content (BMC) and density (BMD) were determined.  
In addition, PSA, serum testosterone and hemoglobin were assessed. 
Results: Upper limb, lower limb, trunk, and whole body LM decreased by 5.6 ± 
0.6%, 3.7 ± 0.5%, 1.4 ± 0.5% and 2.4 ± 0.4% (p < 0.01), respectively, while FM 
increased by 20.7 ± 3.3%, 18.7 ± 2.7%, 12.0 ± 2.5%, and 13.8 ± 2.3% (p < 0.001). 
Hip and spine BMD decreased by 1.5 ± 0.5% and 3.9 ± 0.4% (p < 0.001) as did 
whole body (2.4 ± 0.3%) and upper limb (1.3 ± 0.3%) BMD, but not lower limb 
BMD. Serum testosterone, PSA and hemoglobin decreased by 93.3% ± 0.4, 98.2% ± 
0.5%, and 8.8 ± 0.9 (p < 0.001), respectively.  
Conclusion: Thirty-six weeks of ADT resulted in a significant decrease in whole 
body and regional lean mass and bone mass, while whole body and regional fat mass 
increased in older men with prostate cancer. Strategies to counteract changes in soft 
tissue and bone mass during ADT should be formulated to minimize risk of 
sarcopenia, osteoporosis, and obesity. 
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 EXPERIMENTAL STUDY TWO 
RESISTANCE TRAINING AND REDUCTION OF PHYSICAL 
TREATMENT SIDE EFFECTS IN PROSTATE CANCER 
PATIENTS  
 
Purpose: To examine the effect of progressive resistance training on muscle 
function, functional performance, balance, body composition and muscle thickness in 
men receiving androgen deprivation for prostate cancer.  
Methods: Ten men aged (59-82 years) on androgen deprivation for localised prostate 
cancer undertook progressive resistance training for 20 weeks at 6-12 repetition 
maximum for 12 upper and lower body exercises in a University exercise 
rehabilitation clinic. Outcome measures included muscle strength and muscle 
endurance for the upper and lower body, functional performance (repeated chair rise, 
usual and fast 6-m walk, 6-m backwards walk, stair climb, and 400-m walk time) and 
balance by sensory organization test. Body composition was measured by dual 
energy x-ray absorptiometry and muscle thickness at four anatomical sites by B-
Mode ultrasound.  Blood samples were assessed for PSA, testosterone, growth 
hormone (GH), cortisol, and hemoglobin.   
Results: Muscle strength (chest press, 40.5%; seated row, 41.9%; leg press, 96.3%; p 
< 0.001) and muscle endurance (chest press, 114.9%; leg press, 167.1%; p < 0.001) 
significantly increased following training. Significant improvement (p < 0.05) 
occurred in the 6-m usual walk (14.1%), 6-m backwards walk (22.3%), chair rise 
(26.8%), stair climbing (10.4%), 400-m walk (7.4%) and balance (7.8%). Muscle 
thickness increased (p < 0.05) by 15.7% at the quadriceps site. Whole body lean 
mass was preserved with no change in fat mass. There were no significant changes in 
PSA, GH, testosterone, cortisol, or hemoglobin.   
Conclusions: Progressive resistance exercise has beneficial effects on muscle 
strength, functional performance and balance in older men receiving androgen 
deprivation for prostate cancer and should be considered to preserve body 
composition and reduce physical side effects associated with treatment. 
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Chapter 1 
 
INTRODUCTION 
 
 
 Worldwide 15 million new cases and 10 million new deaths from all cancers 
are expected by the year of 2020 (Parkin, Bray, Ferlay, & Pisani, 2001). In this 
context, prostate cancer is the sixth most common cancer representing 14.3% of 
cancers among men in developed countries (Parkin, Pisani, & Ferlay, 1999). 
Nevertheless, the mortality rate for prostate cancer has declined over the past several 
years in many developed countries (Baade, Coory, & Aitken, 2004). It has been 
suggested that the prostate-specific antigen (PSA) screening that was introduced in 
North America in the late 1980s had a significant role on early detection of the 
disease contributing to the increased survival rates viewed in the last decade (Oliver, 
May, & Gunnell, 2001). Given that the life expectancy from prostate cancer patients 
has increased, clinical interventions aimed at decreasing levels of fatigue, promoting 
physiological and psychological adaptations, and improving quality of life treatment 
are relevant.  
 Recently, Denmeade and Isaacs (2004), in their comprehensive review of the 
historical development of prostate cancer treatments, reported that although there was 
a remarkable increase in the number of prostate cancer diagnostics over the last 150 
years, understanding related to the specific biology of prostate cancer and its 
treatments (androgen deprivation treatment (ADT), prostatectomy, radiation, prostatic 
brachytherapy and systematic therapy) had developed only over the past 30 years. 
The traditional treatments for prostate cancer that focus on reducing the levels or 
effects of testosterone by ADT have many undesirable side effects (Diamond, 
Higano, Smith, Guise, & Singer, 2004; Hedlund, 2000; Holzbeierlein, McLaughlin, & 
Thrasher, 2004; Pickett, Bruner, Joseph, & Burggraf, 2000; Stege, 2000). Some of 
these physical side effects include increased fat mass, reduction of muscle and bone 
mass, altered lipid profiles, anemia and gynecomastia which have negative 
implications for physiological and psychological function (Cassileth et al., 1992; 
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Cleary, Morrissey, & Oster, 1995; Diamond, Higano, Smith, Guise, & Singer, 2004; 
Hedlund, 2000; Holzbeierlein, McLaughlin, & Thrasher, 2004; Michaelson, Marujo, 
& Smith, 2004; Pickett, Bruner, Joseph, & Burggraf, 2000; Stege, 2000).  
 Only scant information on alterations to bone mass and soft-tissue following 
ADT exist (Smith, 2004; Smith et al., 2002; Tayek et al., 1990), and there is no 
information on changes in bone density levels at various regional sites, regional lean 
and fat mass (i.e. trunk, upper, and lower limb) during therapy. Abdominal fat has 
been related to increased risk for the development of cardiovascular complications, 
thus, if ADT tends to induce greater trunk fat accumulation, alternative or adjuvant 
therapies should be devised to counteract such conditions. Similarly, are losses in 
muscle and bone mass greater at weight-bearing sites than non-weight bearing sites 
and can strategies be incorporated into the patient’s management plan to address this?  
Moreover, these changes in body composition and tissue distribution can be directly 
related to chronic conditions that result in disability and loss of independence in older 
adults.  
 Existing treatments to alleviate these side effects have been predominantly 
pharmaceutical, however, these treatments are expensive, with the cost benefit ratio 
questionable and their effects do not translate into improved physical function or 
decreased levels of fatigue (Smith et al., 2003; Smith et al., 2001).  
 Considering that the life expectancy for prostate cancer patients has increased, 
additional information on how bone mass and body composition adapts during ADT 
seems relevant so that appropriate to counter the physiological side effects can be 
devised and recommended.  
 To date, most of the experimental studies examining the role of exercise 
during cancer treatments have included breast cancer patients (MacVicar, 
Winningham, & Nickel, 1989; Mock et al., 1997; Mock et al., 2001; Schwartz, Mori, 
Gao, Nail, & King, 2001; Winningham & MacVicar, 1988; Winningham, M. L., 
M.G. MacVicar, M. Bondoc, J.I. Anderson, & J.P. Minton, 1989) and other types of 
cancer (Cunningham, Morris, & Cheney, 1986; Dimeo, Fetscher, Lange, 
Mertelsmann, & Keul, 1997; Dimeo, Rumberger, & Keul, 1998; Dimeo, Tilman et 
al., 1997; Dimeo, Stieglitz, Novelli-Fischer, Fetscher, & Keul, 1999), but have not 
included prostate cancer patients undertaking ADT. Moreover, most exercise 
interventions included aerobic exercise (Courneya et al., 2003; Dimeo, Fetscher, 
Lange, Mertelsmann, & Keul, 1997; Dimeo, Rumberger, & Keul, 1998; Dimeo, 
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Stieglitz et al., 1997; Dimeo, Tilman et al., 1997; Dimeo, Stieglitz, Novelli-Fischer, 
Fetscher, & Keul, 1999; MacVicar, Winningham, & Nickel, 1989; Mock et al., 1997; 
Mock et al., 2001; Schwartz, 1999; Schwartz, 2000; Segal et al., 2001; Winningham, 
M. L., M. G. MacVicar, M. Bondoc, J. I. Anderson, & J. P. Minton, 1989) rather than 
resistance exercise. In view of the extensive scientific literature supporting resistance 
training as being the most effective anabolic exercise method available for improving 
muscle strength, muscle hypertrophy and bone mineral density (Charette et al., 
1991b; Fiatarone et al., 1990; Fiatarone et al., 1994; Frontera, Meredith, O'Reilly, 
Knuttgen, & Evans, 1988a; Hakkinen et al., 1998a; Hakkinen et al., 1996; Nelson et 
al., 1994; Newton et al., 2002; Taaffe, Pruitt, Pyka, Guido, & Marcus, 1996; Taaffe et 
al., 1994; Wolff, van Croonenborg, Kemper, Kostense, & Twisk, 1999), resistance 
exercises may have a role to play counteracting the catabolic side effects of ADT by 
promoting a sufficient anabolic environment which can lead to positive effects on the 
musculoskeletal system. A preliminary report from Segal and associates (2003) 
recently examined the effects of a short-term period of resistance exercise on patients 
diagnosed with prostate cancer undertaking ADT. Although the results support 
positive psychological and physical outcomes, questions remain as to how specific 
physical and physiological parameters such as muscle function, functional 
performance, balance, body composition and bone mineral density would adapt with 
resistance training in long-term trials. Given the fact that ADT usually occurs over a 
two to three year period, but can also occur over a 20 year time frame (Schroder, 
2000), the role of resistance exercise for prolonged periods of time may be even more 
relevant for reducing the catabolic conditions produced by ADT. Therefore, the 
purpose of the present research is to: 1) explore the available literature in the area of 
exercise interventions during and after cancer therapy and propose possible guidelines 
for exercise during cancer treatment, 2) review and identify the anabolic effects 
following resistance training interventions in older adults, 3) examine the effects of 
ADT in regional body composition, bone mass, bone markers and hemoglobin in a 
large cohort of men with localized prostate cancer receiving maximal androgen 
blockage by Luteinizing Hormone-Realizing Hormone Agonist (LRHRa) and  
antiandrogen during 36 weeks, and  4) investigate the effects of a 20-week high 
intensity progressive resistance training on muscle function, functional performance, 
balance, body composition, muscle thickness, bone mineral density, serum hormones 
and PSA in prostate cancer patients on undergoing established ADT. 
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SIGNIFICANCE 
 
 Considering the notable impact of prostate cancer in the male population 
world wide and that the life expectancy from prostate cancer patients has increased, 
clinical interventions aimed to decrease levels of fatigue, promote physical and 
physiological adaptations and improve quality of life during treatment are necessary. 
Thus, resistance exercise may have a potential role to counteract the catabolic side 
effects of ADT promoting a sufficient anabolic environment that can lead to positive 
effects on the musculoskeletal system. Moreover, because ADT may be continued for 
as long as 20 years, the role of resistance exercises may be especially relevant in 
improving physical and  physiological parameters and consequently, quality of life. 
As such, the findings from this study may have important application to exercise 
prescription in prostate cancer patients undertaking ADT.    
 
PURPOSE 
 
The aims of this project are to test several research questions: 
Experiment 1:  
1) Is regional body composition affected following maximal androgen blockage 
in prostate cancer patients?  
2) Is regional bone mineral density affected following maximal androgen 
blockage in prostate cancer patients?  
3) Are levels of hemoglobin and bone markers altered following maximal 
androgen blockage in prostate cancer patients?  
Experiment 2: 
1) Is muscle function increased following resistance exercise in prostate cancer 
patients?  
2) Is functional performance increased following resistance exercise in prostate 
cancer patients?  
3) Is balance improved following resistance exercise in prostate cancer patients? 
4) Is body composition (total lean and fat mass) altered following resistance 
exercise in prostate cancer patients? 
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5) Is muscle thickness increased following resistance exercise in prostate cancer 
patients? 
6) Are systemic levels of serum hormones, PSA, and blood cells altered 
following resistance exercise in prostate cancer patients? 
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DEFINITIONS OF TERMS 
 
Prostate cancer: “A malignant tumor (carcinoma) of the prostate gland, a common 
cancer in elderly men. In most men it progresses slowly over many years and the 
gives symptoms similar to those of benign enlargement of the prostate.”(Martin, 
2002) 
 
Prostate Specific Antigen (PSA): “An enzyme produced by the glandular epithelium 
of the prostate. Increased quantities are secreted when the glands enlarge, and levels 
of PSA in the blood are significantly elevated in cancer of the prostate. Although 
there is no clear “cut-off” level for normality, over 4 ng/ml in the blood is associated 
with a 20% risk of prostate cancer, even in patients with normal-feeling prostates on 
rectal examination. Newer PSA assays can measure free PSA and compare it to the 
total PSA in the blood. Low free: total PSA ratios indicate greater risk of prostate 
cancer and improve the discrimination between cancer and benign disease in men 
with PSA in the range 4-10ng/mg. PSA levels tend to be much higher in advanced 
prostate cancer and the rate of fall on the treatment is a good prognostic indicator of 
response.” (Martin, 2002) 
 
Sarcopenia: The loss of muscle mass with aging (Evans, 1995). 
 
Osteoporosis: “Loss of bony tissue, resulting in bones that are brittle and liable to 
fracture. Infection, injury and synovitis can cause localised osteoporosis of adjacent 
bone. Generalised osteoporosis is common in the elderly, and in women often follows 
menopause. It is also a feature of Cushing’s syndrome and prolonged steroid therapy. 
Osteoporosis can be detected by the quantitative digital radiography and by DEXA 
scans. A diet with adequate calcium, exercise, and hormone replacement are 
preventative, and bisphosphonates can be used to reduce or halve further bone loss.” 
(Martin, 2002) 
 
Dual X-ray absorptiometry (DXA): “A method of measuring bone mineral density 
based on the proportion of a beam of photons that passes through the bone.” (Martin, 
2002) 
Chapter 2 
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Introduction 
 
 
 A progressive increase of cancer burden with an estimated 15 million new 
cases and 10 million new deaths are expected by the year of 2020 (Parkin, Bray, 
Ferlay, & Pisani, 2001). In this context, prostate cancer is the sixth most common 
cancer in the world representing 14.3% of cancers among men in developed 
countries with more than 80% of the cases occurring in men older than 65 years 
(Parkin, Pisani, & Ferlay, 1999). Breast cancer appears as the third most common 
cancer in the world and it is ranked as the fifth most prevalent cause of death from 
cancer overall being the leading cause of cancer mortality in women (Parkin, Pisani, 
& Ferlay, 1999). Treatments for cancer include surgery, systemic and radiation 
therapy and have successfully shown reductions in mortality rates. However, for 
cancer patients, the increased levels of fatigue during treatment remains a concern as 
it affects the majority of patients during radiotherapy and/or chemotherapy periods 
compromising their physical function and quality of life (Dimeo, 2002; Dimeo, 2001; 
Irvine, Vincent, Graydon, Bubela, & Thompson, 1994; Irvine, Vincent, Graydon, & 
Bubela, 1998; Smets, Garssen, Schuster-Uitterhoeve, & de Haes, 1993; Smets, 
Visser, Willems-Groot, Garssen, Oldenburger et al., 1998; Smets, Visser, Willems-
Groot, Garssen, Schuster-Uitterhoeve et al., 1998). Dimeo (2002; , 2001) has 
proposed that the lack of physical activity during treatment may affect the increased 
levels of fatigue observed during and after cancer management. As such, several 
studies examining the role of exercise with cancer patients have linked the increased 
levels of physical activity during (Adamsen et al., 2003; Courneya et al., 2003; 
Dimeo, Fetscher, Lange, Mertelsmann, & Keul, 1997; Dimeo, Rumberger, & Keul, 
1998; Dimeo et al., 2003; Dimeo, Stieglitz et al., 1997; Dimeo, Stieglitz, Novelli-
Fischer, Fetscher, & Keul, 1999; Kolden et al., 2002; MacVicar, Winningham, & 
Nickel, 1989; Mock et al., 1997; Mock et al., 2001; Na, Kim, Kim, Ha, & Yoon, 
2000; Segal et al., 2003; Winningham, M. L., M.G. MacVicar, M. Bondoc, J.I. 
Anderson, & J.P. Minton, 1989) and after cancer treatment (Dimeo, Tilman et al., 
1997; Durak & Lilly, 1998; Durak, Lilly, & Hackworth, 1999; Nieman et al., 1995; 
Peters, Lotzerich, Niemeier, Schule, & Uhlenbruck, 1994; Peters, Lotzerich, 
Niemeir, Schule, & Uhlenbruck, 1995; Porock, Kristjanson, Tinnelly, Duke, & 
Blight, 2000; Segar et al., 1998; Sharkey, Carey, Heise, & Barber, 1993) with 
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positive effects on decreasing rates of fatigue, enhancing physical performance and 
quality of life. However, the majority of the exercise interventions undertaken with 
this population have focused on cardiovascular training (Courneya et al., 2003; 
Dimeo, Fetscher, Lange, Mertelsmann, & Keul, 1997; Dimeo, Rumberger, & Keul, 
1998; Dimeo, Stieglitz et al., 1997; Dimeo, Tilman et al., 1997; Dimeo, Stieglitz, 
Novelli-Fischer, Fetscher, & Keul, 1999; MacVicar, Winningham, & Nickel, 1989; 
Mock et al., 1997; Mock et al., 2001; Schwartz, 1999; Schwartz, 2000; Segal et al., 
2001; Winningham, M. L., M. G. MacVicar, M. Bondoc, J. I. Anderson, & J. P. 
Minton, 1989), with few studies using the combination of aerobic and resistance 
exercises (Adamsen et al., 2003; Durak & Lilly, 1998; Durak, Lilly, & Hackworth, 
1999; Kolden et al., 2002; Nieman et al., 1995; Porock, Kristjanson, Tinnelly, Duke, 
& Blight, 2000) or resistance exercise alone (Cunningham, Morris, & Cheney, 1986; 
Segal et al., 2003). Therefore, little is known as to the effect of resistance training 
being a primary exercise choice to counteract some of the physiological conditions 
accompanied by cancer disease and the traditional treatments. Considering that most 
of the experimental exercise studies have incorporated breast cancer patients 
(MacVicar, Winningham, & Nickel, 1989; Mock et al., 1997; Mock et al., 2001; 
Schwartz, Mori, Gao, Nail, & King, 2001; Winningham & MacVicar, 1988; 
Winningham, M. L., M.G. MacVicar, M. Bondoc, J.I. Anderson, & J.P. Minton, 
1989) and other types of cancer (Cunningham, Morris, & Cheney, 1986; Dimeo, 
Fetscher, Lange, Mertelsmann, & Keul, 1997; Dimeo, Rumberger, & Keul, 1998; 
Dimeo, Tilman et al., 1997; Dimeo, Stieglitz, Novelli-Fischer, Fetscher, & Keul, 
1999) but not prostate cancer, there is a particular lack of information on how 
prostate cancer patients undertaking traditional treatment would respond to an 
exercise program and yet given the documented effects of androgen deprivation 
therapy (ADT) (Cassileth et al., 1992; Cleary, Morrissey, & Oster, 1995; Diamond, 
Higano, Smith, Guise, & Singer, 2004; Hedlund, 2000; Holzbeierlein, McLaughlin, 
& Thrasher, 2004; Michaelson, Marujo, & Smith, 2004; Pickett, Bruner, Joseph, & 
Burggraf, 2000; Stege, 2000) these patients should benefit particularly from 
resistance exercise. To date, only one published paper has examined the effects of a 
short-term resistance exercise program on patients diagnosed with prostate cancer 
and undertaking ADT (Segal et al., 2003). Interestingly, they reported quite 
promising results. In view of the extensive scientific literature supporting resistance 
training as being the most effective method available for improving muscle strength 
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and increasing lean tissue mass in different populations ranging from athletes to frail 
older adults (Charette et al., 1991b; Fiatarone et al., 1990; Fiatarone et al., 1994; 
Frontera, Meredith, O'Reilly, Knuttgen, & Evans, 1988a; Hakkinen et al., 1998a; 
Hakkinen et al., 1996; Kraemer et al., 1999b; Kraemer et al., 2003; Newton et al., 
2002; Taaffe, Pruitt, Pyka, Guido, & Marcus, 1996; Taaffe et al., 1994), resistance 
exercise may also have a great potential to counteract the side effects of prostate 
cancer during ADT by increasing muscle function, lean tissue mass and bone mineral 
density with subsequent reduction in levels of fatigue.  
 There are specific training variables involving resistance exercise prescription 
which include number of sets and repetitions (volume), intensity of training (load), 
duration of rest between sets and exercises, frequency of training and repetition 
velocity (American College of Sports Medicine, 1998b; Kraemer et al., 2002; 
Kraemer & Ratamess, 2004). Currently, there is no information with regard to such 
training variables and possible variations with cancer patients undertaking resistance 
training programs. Interestingly, some of these variables have been examined in 
untrained older adults (Galvão & Taaffe, 2004; Hunter et al., 2001; Taaffe, Duret, 
Wheeler, & Marcus, 1999; Taaffe, Pruitt, Pyka, Guido, & Marcus, 1996; Vincent et 
al., 2002) and favourable responses in strength and function result from a variety of 
training regimens, even those that involve relatively low intensities (Taaffe, Pruitt, 
Pyka, Guido, & Marcus, 1996; Vincent et al., 2002; Vincent, Vincent, Braith, 
Bhatnagar, & Lowenthal, 2003), frequencies (Taaffe, Duret, Wheeler, & Marcus, 
1999) and volume (Galvão & Taaffe, 2004; Taaffe & Galvão, 2004). Considering the 
detrained state and high levels of fatigue of many cancer patients, it may be expected 
that even a training program consisting of lower intensity, volume and frequency 
could significantly promote positive physiological and psychological adaptations 
increasing quality of life in this population.  
 The purpose of this paper is to present a descriptive overview and 
chronological perspective of developments of the experimental exercise intervention 
studies undertaken during and after cancer management. The second aim of this 
review attempts to establish a dose response of training for this population 
considering type of exercise, frequency of training, volume of training, intensity of 
training and expected physiological outcome measures. In addition, we also highlight 
specific points that should be examined in the future with the goal of obtaining more 
information on exercise prescription for this population. This review reports 26 
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published studies appearing in the Medline (electronic version of Index Medicus) 
database, published by June of 2004 and searched by the terms: exercise; 
cardiovascular training; resistance training; rehabilitation; and cancer.  Secondary 
searching involved scanning the reference lists from the papers identified above and 
then locating papers which appeared useful in reviewing the topic.  A key criterion 
throughout this process was identifying studies which incorporated pre- and post-
intervention assessment with statistical analysis of the data.  
 
 
Experimental Exercise Studies during Cancer Treatment 
 
 A summary of the published studies examining the effect of exercise on 
cancer patients undertaking treatment is shown in Table I. Out of the 18 experimental 
exercise interventions under cancer treatment, 14 had used some type of 
cardiovascular training (Courneya et al., 2003; Dimeo, Fetscher, Lange, 
Mertelsmann, & Keul, 1997; Dimeo, Rumberger, & Keul, 1998; Dimeo et al., 2003; 
Dimeo, Stieglitz, Novelli-Fischer, Fetscher, & Keul, 1999; MacVicar, Winningham, 
& Nickel, 1989; Mock et al., 1997; Mock et al., 2001; Na, Kim, Kim, Ha, & Yoon, 
2000; Schwartz, 1999; Schwartz, 2000; Schwartz, Mori, Gao, Nail, & King, 2001; 
Segal et al., 2001; Winningham & MacVicar, 1988; Winningham, M. L., M.G. 
MacVicar, M. Bondoc, J.I. Anderson, & J.P. Minton, 1989), two  had used a mixed 
training program using cardiovascular, resistance and flexibility exercises (Adamsen 
et al., 2003; Kolden et al., 2002) while the other two studies applied a structured 
resistance training program (Cunningham, Morris, & Cheney, 1986; Segal et al., 
2003). The main outcome measures from these studies include: levels of fatigue 
(Mock, 2001a; Mock et al., 1997; Schwartz, 1999; Schwartz, Mori, Gao, Nail, & 
King, 2001; Segal et al., 2003), quality of life, emotional-related distress (Adamsen 
et al., 2003; Courneya et al., 2003; Dimeo, Stieglitz, Novelli-Fischer, Fetscher, & 
Keul, 1999; Kolden et al., 2002; Mock et al., 1997; Mock et al., 2001; Schwartz, 
1999; Segal et al., 2001), immunological parameters (Dimeo, Fetscher, Lange, 
Mertelsmann, & Keul, 1997; Dimeo et al., 2003; Dimeo, Tilman et al., 1997; Na, 
Kim, Kim, Ha, & Yoon, 2000), aerobic capacity (Adamsen et al., 2003; American 
College of Sports Medicine, 1998b; Courneya et al., 2003; Dimeo, Fetscher, Lange, 
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Mertelsmann, & Keul, 1997; Dimeo, Rumberger, & Keul, 1998; Dimeo et al., 2003; 
Dimeo, Stieglitz, Novelli-Fischer, Fetscher, & Keul, 1999; Kolden et al., 2002; 
MacVicar, Winningham, & Nickel, 1989; Mock et al., 1997; Mock et al., 2001; 
Schwartz, 1999; Schwartz, Mori, Gao, Nail, & King, 2001; Segal et al., 2001; 
Winningham, M. L., M.G. MacVicar, M. Bondoc, J.I. Anderson, & J.P. Minton, 
1989) and muscle strength (Adamsen et al., 2003; Kolden et al., 2002; Segal et al., 
2003).   
A. Cardiovascular training 
 
 The first study by Winningham and colleagues (1988) examined the effect of 
a 10-week aerobic program performed three times per week on nausea responses of 
breast cancer patients undertaking chemotherapy. Subjects were randomly assigned 
to an exercise, placebo or control group. The exercise group improved significantly 
more on symptoms of nausea compared to control and placebo (P < 0.05). 
Considering that nausea is a consistent symptom experienced by cancer patients 
during treatment, this preliminary data showed that cardiovascular training can safely 
be incorporated during breast cancer traditional treatment and may decrease 
symptoms of nausea. Winningham and colleagues (1989) also presented data related 
to a sub-group of their earlier report (Winningham & MacVicar, 1988) which 
examined the effect of a 10- to 12-week aerobic training program on body 
composition responses of breast cancer subjects undertaking chemotherapy. Subjects 
were randomly allocated to an exercise group which trained 3 times per week for 20-
30 minutes with intensity set at 60-80% of maximal heart rate or a control group 
which did not receive the exercise treatment. Although elementary techniques for 
body composition determination were used in this intervention, the results showed 
enhanced adaptations for lean tissue mass of the training group compared to the 
control group. Considering the specificity of the training program in this study 
(aerobic exercise only), the relative increase in lean tissue mass may be attributed to 
the decreased fat tissue. 
 The effect of a 10-week aerobic interval training program was also 
investigated by MacVicar and associates (1989). Forty-five women with breast 
cancer receiving chemotherapy were randomly assigned to an aerobic exercise group 
(cycling training), a flexibility training group or a control group. Exercise intensity 
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was set at 60-85% of the maximum heart rate reserve. Results demonstrated 
differences for maximum oxygen uptake (VO2max) and testing time among groups 
with the aerobic training group improving significantly more than the flexibility and 
control group.    
 Mock and colleagues (1997) examined the effect of a home based exercise 
program on women with breast cancer undertaking radiotherapy. The exercise 
program consisted of a 20-30 minute self-paced walking program, 4-5 times per 
week over 6 weeks. A 12-Minute Walk Test, Symptom Assessment Scales and the 
Piper scale were used to assess physical function, symptoms experience and fatigue, 
respectively. Results showed that subjects undertaking the exercise program had a 
significant improvement in walking distance, symptom experience (anxiety, 
depression and difficulty sleeping) and fatigue.      
 The effect of a daily bed cycling program during high-dose chemotherapy 
treatment in cancer patients followed by autologous peripheral blood cells 
transplantation was reported by Dimeo and associates (1997). Subjects from the 
control group experienced significantly higher loss of physical performance levels 
during hospitalization than the exercise group (p < 0.05). Moreover, other 
physiological parameters such as duration of neutropenia, thrombopenia and severity 
of diarrhea were significantly reduced after the exercise intervention (p < 0.05). 
Dimeo and colleagues (1998) also reported the response of a 6-week  cardiovascular 
exercise program on fatigue and physical performance in a small sample of cancer 
patients (n = 5) experiencing fatigue during treatment. A progressive walking 
treadmill program up to 30-35 minutes with intensity set to elicit a blood lactate level 
of 3 mmol.L in capillary blood was prescribed. At the end of the intervention, 
walking distance, walking maximal performance, heart rate and lactate concentration 
were improved (p < 0.05) demonstrating once more positive physiological responses 
accrued with cardiovascular training. In addition, the authors also noted a clear 
decrease in levels of fatigue at post-test. Subsequently in 1999, the same group of 
investigators (Dimeo, Stieglitz, Novelli-Fischer, Fetscher, & Keul, 1999) also 
examined a daily exercise protocol consisting of a supine bike program followed by 
an interval training pattern for 30 minutes in cancer patients receiving high doses of 
chemotherapy. Outcome measures included psychological distress and levels of 
fatigue. It was demonstrated at the end of the intervention that subjects undertaking 
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the exercise program significantly decreased psychological distress with no changes 
in fatigue levels.       
 Schwartz and colleagues (2000; , 1999) reported results from a 8-weeks 
exercise intervention in women with breast cancer undertaking chemotherapy. The 
exercise program included a home-based walking program with self-paced intensity 
measured by an accelerometer. Subjects who underwent the exercise program 
demonstrated greater response in the physical performance assessment (12-minute 
walk test), as well as decreasing levels of fatigue compared to subjects who did not 
adopt the training program (p < 0.05).   
 The short-term effect of cardiovascular training on natural killer cell 
cytotoxic activity (NKCA) in stomach cancer patients were reported by Na and 
associates (2000). Subjects were assigned to an exercise group which performed 30 
minutes of supervised cardiovascular training using arm and cycle ergometer or a 
non-exercise control group. Blood samples were collected at baseline, day 7 and day 
14. At post-test a significantly greater increase in NKCA was noted for the exercise 
group (27.9%) compared to the control group (13.3%) (p < 0.05).  Although the 
training period was short in duration, it is interesting to note that both groups had 
similar values for NKCA at the midpoint of intervention, with the differences 
between groups occurring during the second half of the training period.  
 Schwartz and colleagues (2001) also investigated the relationship of fatigue 
and exercise through a home-based aerobic exercise program consisting of a 12-
minute walk in women undergoing chemotherapy treatment for breast cancer. 
Functional abilities were assessed through a 12-minute walk test and fatigue levels 
by a self-reported instrument. The exercise program increased functional ability by 
15% whereas the non-exercisers decreased performance by 16%. In addition, 
decreased levels of fatigue (p < 0.01) for the exercise group were observed after the 
intervention. It is interesting to note that the exercise program was unsupervised with 
none of the sessions being accompanied by an exercise physiologist. Considering 
that training program variables were not well controlled during training, the results 
are somewhat attractive and one would expect even greater adaptations for an 
exercise program that incorporates a more controlled setting resulting in an enormous 
impact on the outcome measures with this population. 
 The effect of a similar home-based walking exercise intervention on breast 
cancer patients undertaking either radiotherapy or chemotherapy was also examined 
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by Mock and colleagues (2001). The exercise program consisted of a progressive 
walking (10-30 minutes) program 5 to 6 days per week with an unspecified training 
intensity. Similar to Schwartz and colleagues (2001) and their previous report (Mock 
et al., 1997), physical function was assessed by the 12-Minute Walk Test. In addition 
fatigue and emotional distress were measured by the Pipe scale and Profile of Mood 
States (POMS), respectively. Consistent with their previous findings (Mock et al., 
1997), the exercise intervention lead to a significant improvement in physical 
performance by increasing walking distance. Additionally, fatigue and emotional 
distress were enhanced at post-test indicating once more that positive psychological 
outcomes may be achieved with a simple home-based walking exercise program.  
 Segal and colleagues (2001) conducted a randomized controlled trial 
examining the effect of a supervised and unsupervised walking program on breast 
cancer patients undertaking treatment (radiotherapy, hormonal therapy or 
chemotherapy) over 26 weeks. Aerobic capacity, body weight and generic and 
disease-specific health related quality of life were assessed (MOS SF-36) at baseline 
and post-test. Results demonstrated that physical function measured by the MOS SF-
36 decreased in the control group while it increased in both training groups (p < 
0.05). At post-test, no differences among groups were detected for quality of life, 
aerobic capacity or body weight. However, when groups were stratified by type of 
adjuvant therapy, in this case not receiving chemotherapy, differences in 
improvement were observed between the supervised and control group for aerobic 
capacity (p < 0.01). It is relevant to point out that the small changes in aerobic 
capacity (3.5%) may be related to the nonspecific aerobic capacity test protocol 
(stepping ergometer) utilized by the authors to assess chronic response of a walking 
program. 
The effect of  2-weeks of cardiovascular training on a mixed cancer 
population undergoing conventional or high-dose chemotherapy during 
hospitalization was examined by Dimeo and associates (2003). The training program 
consisted of a daily walking treadmill interval training program with intensity set at 
70% of the maximum heart rate. Submaximal stress test results demonstrated that 
physical performance remained unaltered during treatment with significant 
reductions in hemoglobin levels at hospital discharge (p < 0.05). Although physical 
performance did not change at post-test, results demonstrated that cardiovascular 
training may assist on preserving performance status during intensive chemotherapy. 
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Finally, Courneya and associates (2003) conducted a randomized controlled 
trial examining the effect of a home based exercise program on quality of life and 
cardiovascular capacity of colorectal cancer patients undertaking adjuvant therapy. 
The exercise group was instructed to perform cardiovascular and flexibility activities 
3-5 times per week over 16 weeks while the control group advised to not participate 
in any exercise activity during the study period. No significant differences were 
observed between groups for quality of life and cardiovascular capacity at the end of 
the intervention. The failure to detect differences between groups is primarily 
explained by the fact that 51.6% of the control group did not comply with the study 
and exercised during the study period. The nature of the exercise itself (home based 
program) was pointed out by the authors as being one possible reason of the high 
contamination during the intervention with little effectiveness.  
 
 
 
B. Cardiovascular, resistance and flexibility training 
 
 Kolden and associates (2002) examined the effect of an exercise training 
intervention including cardiovascular, resistance and flexibility training over 16 
weeks in breast cancer patients undertaking some type of adjuvant therapy 
(radiotherapy, chemotherapy or hormonal therapy). Subjects were tested for resting 
blood pressure, body composition, aerobic capacity, flexibility and strength. In 
addition, numerous psychological outcomes were also examined using the Beck 
Depression Inventory, State-Trait Anxiety Inventory, Positive and Negative Affect 
Schedule, Hamilton Scale for Depression, Quality of Life and Global Assessment 
Scale. At the end of the intervention, there was an observed effect for time for upper 
and lower body strength, cardiovascular capacity (estimated VO2 maximum), 
flexibility, and resting systolic blood pressure (p < 0.05). Additionally, subjects 
experienced positive psychological adaptations with training improving some of the 
Quality of Life measures.  
 Recently, Adamsen and colleagues (2003), examined the effect of a high 
intensity supervised exercise program on a mixed cancer population over 6-weeks. 
The training program included interval training with intensity set at 60 to 100% of 
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the maximal heart rate, resistance exercises performed at 85 to 95% of 1-RM for 5-8 
repetitions and relaxation training. The results demonstrated an increase of 32.5% in 
maximal strength (p < 0.0001) and 16% improvement in VO2max (p < 0.001). 
Several measures of quality of life were also improved however no statistical 
significant were noted. It is relevant to highlight that this is the first study which 
incorporates a higher intensity training design, however, the absence of a control 
group and the short duration of the intervention limited the interpretation of the data.  
 
C. Resistance training 
 
 The earliest published study examining the effects of resistance exercise was 
a short-term intervention involving patients with acute leukemia undertaken by 
Cunningham and associates (1986). Subjects were randomly assigned to two exercise 
groups performing the program either three or five times weekly or a non-exercising 
control group. The training program consisted of several upper and lower body 
exercises including the chest press, biceps curl, triceps extension, straight leg raises, 
knee extension, hip extension, hip abduction, shoulder retractors and sit-ups 
performed with 15 repetitions at an unspecified intensity. Outcome measures 
included skinfold measures, arm circumference, nitrogen balance and creatinine 
excretion. Results indicated that groups did not change arm circumference and 
skinfold measures over the course of the intervention. Although, there were no 
differences among groups for nitrogen balance during the course of the study, the 
authors suggested that the exercise program favored both training groups with the 
control group decreasing levels of creatinine excretion from pre-to post-test (p < 
0.05). 
 Recently, Segal and colleagues (2003) reported the results from a 12-week 
whole body resistance training intervention in prostate cancer patients undergoing 
ADT. The resistance training program consisted of two sets of eight to 12 repetitions 
at 60 to 70% of 1RM for six upper body and three lower body exercises performed 
three times per week. Outcome measures included fatigue, disease-specific quality of 
life assessment, and muscle strength and body composition. Results showed positive 
effects of resistance training on decreasing fatigue levels, health-related quality of 
life and muscle strength with no changes in body composition by the subjects 
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embarking on the exercise program. The fact that body composition was unaffected 
by the training program may be related in part to the elementary body composition 
methods used to assess changes in muscle and fat tissue. In addition, it is well know 
that strength gains during the first stages of resistance training are predominantly due 
to neural factors with gains in muscle size becoming dominant as training continues 
(Sale, 1987, 1988; Sale, MacDougall, Upton, & McComas, 1983). Consequently, the 
shorter duration of the intervention and the limitations on body composition 
assessment methods indicated that increases in strength were likely to be related to 
neural alterations rather than muscle morphological changes. This preliminary data 
showed optimistic outcomes with a resistance training program which is 
characterized primarily by anaerobic energy sources rather than aerobic. Taking into 
consideration that immunological parameters were not assessed in this particular 
study, it remains to quantify if resistance training may positively alter the immune 
system of patients under cancer treatment. In addition, it would be interesting to 
examine how other types of cancer patients would respond with resistance exercises.  
Experimental Exercise Studies after Cancer Treatment  
 
 Experimental studies examining the effect of exercise on cancer patients after 
treatment are presented in Table II. Four studies had used cardiovascular exercise 
programs (Dimeo, Tilman et al., 1997; Peters, Lotzerich, Niemeier, Schule, & 
Uhlenbruck, 1994; Peters, Lotzerich, Niemeir, Schule, & Uhlenbruck, 1995; Segar et 
al., 1998; Sharkey, Carey, Heise, & Barber, 1993) while the other four implemented 
a mixed training program using cardiovascular, resistance and flexibility exercises 
(Durak & Lilly, 1998; Durak, Lilly, & Hackworth, 1999; Nieman et al., 1995; 
Porock, Kristjanson, Tinnelly, Duke, & Blight, 2000). Levels of fatigue, muscle 
strength (Durak & Lilly, 1998; Nieman et al., 1995), cardiovascular function (Dimeo, 
Tilman et al., 1997; Durak & Lilly, 1998; Durak, Lilly, & Hackworth, 1999; Nieman 
et al., 1995; Peters, Lotzerich, Niemeier, Schule, & Uhlenbruck, 1994; Peters, 
Lotzerich, Niemeir, Schule, & Uhlenbruck, 1995; Sharkey, Carey, Heise, & Barber, 
1993), immunological parameters (Dimeo, Tilman et al., 1997; Nieman et al., 1995; 
Peters, Lotzerich, Niemeier, Schule, & Uhlenbruck, 1994; Peters, Lotzerich, 
Niemeir, Schule, & Uhlenbruck, 1995), symptoms of emotional-related distress and 
quality of life (Durak & Lilly, 1998; Durak, Lilly, & Hackworth, 1999; Peters, 
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Lotzerich, Niemeier, Schule, & Uhlenbruck, 1994; Porock, Kristjanson, Tinnelly, 
Duke, & Blight, 2000; Segar et al., 1998) were the major outcome measures from 
these studies.  
 
A. Cardiovascular training 
 
 Sharkey and associates (1993) conducted the first experimental exercise study 
examining the chronic response of a 12-week cardiovascular training program on 
children and young adults with mixed cancer diagnosis who had completed 
chemotherapy for at least one year. Outcome measures included cardiovascular and 
pulmonary physiological responses. Although, none of the physiological parameters 
changed with training, exercise tolerance assessed by exercise time was increased 
significantly (p < 0.05). 
 The effect of cardiovascular training on NKCA, monocytes and personality 
was examined in a group of breast cancer survivors by Peters and colleagues (1994; , 
1995). Their training program consisted of 30-40 minutes cycling at approximately 
60% of maximum heart rate performed five times per week during the first five 
weeks of training with a subsequent reduction of training frequency for the following 
six months completing a total 7 months training period. Although NKCA cell 
numbers were unaltered over the course of the intervention, an increase in the 
cytotoxic activity was noted at post-test. While the total number of leukocytes was 
unchanged after the training program, significant changes in leukocyte sub-
populations was detected with an increased number of granulocytes and a decreased 
number of lymphocytes and monocytes (p < 0.05). The authors suggested that 
cardiovascular training would possibly alter the number of specific receptors in the 
surface membrane on monocytes. Moreover, satisfaction of life increased in the first 
five weeks of training with a subsequent decrease during the other 6 months of the 
intervention. 
 Dimeo and colleagues (1997) examined the effects of a cardiovascular 
training program on maximal performance and hemoglobin levels of cancer patients 
directly after hospital discharge. The exercise program consisted of 6-weeks 
treadmill walking every week day with intensity set to  elicit a blood lactate 
level of 3 mmol.L in capillary blood. Results indicated that subjects that underwent 
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the exercise program showed a significant increase in maximal performance and 
hemoglobin concentration compared to controls (p < 0.05).  
 The effects of 10 weeks of cardiovascular exercises on women who had 
undergone breast cancer treatment were examined by Segar (1998) and associates. 
Subjects were randomly allocated to an exercise group, exercise plus behavior 
modification group or a control group in an experimental cross over design. 
Symptoms of depression, state of anxiety and self-esteem were assessed by the Beck 
Depression Inventory, the State Anxiety Inventory and the Rosenberg Self-Esteem 
Inventory, respectively. At post-test, it was observed that the exercise group had 
significantly less depression and state of anxiety compared to controls with no 
differences between exercise and exercise plus behavior modification groups. After 
the crossover, the controls also showed optimistic changes by decreasing depression 
and state of anxiety showing positive psychological response accrued with 
cardiovascular training.   
B. Cardiovascular, resistance and flexibility training 
 
 The effects of an exercise program on breast cancer survivors who had 
undergone surgery, radiation and chemotherapy were examined by Nieman and 
colleagues (1995). Subjects were randomly assigned to an exercise or control group. 
In addition to physical performance measures that included; symptoms-limited 
exercise testing on the treadmill, 6-minute walk test and lower body strength, 
immunological training response was also assessed by measuring NKCA and 
concentrations of circulating immune cells. The training program included 30 
minutes walking at 75% of heart rate maximum and seven different resistance 
exercises performed for 12 repetitions at an unspecified intensity. Results indicated 
significant improvement for the exercise group on six-minute walk distance test 
compared to controls (p < 0.05). However, differences between groups were neither 
observed for lower body strength nor natural killer cell cytotoxic activity. It should 
be noted that the small sample size (n = 6 per group) limited the ability to detect 
significant difference between groups.   
 Durak and colleagues (1998b) conducted an exercise intervention in a mixed 
cancer patient population over 10 weeks. The exercise program was performed twice 
weekly and consisted of cardiovascular training at their own perceived exertion, 
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resistance training machines using unspecified intensity and flexibility exercises. 
Outcome measures included quality of life (Modified Rotterdam Quality of Life 
Survey), endurance capacity and a 4- to 6-repetition maximum strength test. Results 
demonstrated an average increase of 43% for both upper and lower body strength 
combined and a 41.4% increase in MET level from the first to the last session of the 
exercise program. In addition, the quality of life assessment indicated a significant 
improvement on participants’ ability to perform daily functions. The same group of 
investigators (Durak, Lilly, & Hackworth, 1999) also examined the effect of a 20-
week cardiovascular and resistance training program on prostate, carcinoma and 
leukemia survivors. The exercise protocol was described with little detail in the 
original manuscript; therefore it is unclear what intensity and volume were applied 
during the exercise intervention for both cardiovascular and resistance exercises. In 
addition, neither strength maximum nor cardiovascular capacity tests were 
implemented at pre-and post test becoming extremely difficult to analyze the authors 
presented data. At post-test, subjects completed a quality of life survey with the same 
questionnaire being reassessed in a two year follow-up period. It was reported that 
the training protocol induced an increase of 38% and 52% for overall strength in the 
prostate cancer and carcinoma/leukemia group, respectively. No significant change 
was noted for aerobic capacity. It is interesting to point out the high level of 
adherence to the exercise program from both groups with subjects from the prostate 
cancer group having 100% compliance to the training program whereas the 
carcinoma/leukemia group recorded 65% of adherence over the two year period.  
 Finally, Porock and associates (2000) investigated the effect of a short-term 
home based exercise intervention in a mixed population of cancer patients. The 
training program appears to include both cardiovascular and resistance exercises but 
lacked an exact description of training program variables (intensity, frequency and 
volume). Outcome measures included fatigue, anxiety, depression, symptoms of 
distress and quality of life. Results indicated positive adaptations for depression and 
anxiety with no change in fatigue levels. It should be noted that the short-term 
duration of the intervention and the small sample size (n = 9) limited the ability to 
detect significant changes with training. 
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Discussion 
 
 The primary aim of this paper was to present an overview of published 
studies undertaken with any cancer population during and after treatment. 
Unfortunately, most of these studies suffer limitations because they are not 
randomized controlled trials, use small sample sizes and/or report insufficient 
scientific methodological criteria. Despite this, it appears that there is a reasonable 
amount of data in the literature which underline preliminary positive physiological 
and psychological benefits from exercise when undertaking during or after traditional 
cancer treatment. It is interesting to point out that the early published report on 
cancer and exercise by Cunningham and associates (1986) used resistance exercises 
as the training modality which was based on the original work by Delorme (1948; , 
1950) who introduced the model of progressive workload with resistance exercises. 
Subsequently, the majority of studies examining the effect of exercise on cancer 
patients undertaking treatment completed from the late 1980’s to 2003 implemented 
the cardiovascular training modality (Courneya et al., 2003; Dimeo, Fetscher, Lange, 
Mertelsmann, & Keul, 1997; Dimeo, Rumberger, & Keul, 1998; Dimeo, Stieglitz, 
Novelli-Fischer, Fetscher, & Keul, 1999; MacVicar, Winningham, & Nickel, 1989; 
Mock et al., 1997; Mock et al., 2001; Na, Kim, Kim, Ha, & Yoon, 2000; Schwartz, 
1999; Schwartz, 2000; Schwartz, Mori, Gao, Nail, & King, 2001; Segal et al., 2001; 
Winningham & MacVicar, 1988; Winningham, M. L., M. G. MacVicar, M. Bondoc, 
J. I. Anderson, & J. P. Minton, 1989) with only two intervention using the 
combination of resistance, flexibility and cardiovascular training (Adamsen et al., 
2003; Kolden et al., 2002). Therefore, particular attention should be taken of the 
recent report from Segal and colleagues (2003) who reported positive effects of 
resistance exercises alone on rates of fatigue, health-related quality of life and muscle 
strength in prostate cancer patients undertaking ADT. Although these results support 
positive psychological and physical outcomes, it remains to be examined how 
specific physiological parameters such as muscle tissue mass and bone mineral 
density would respond with resistance exercises in this population especially in long 
term trials. Recently, Smith and associates (2004) reported an increase of 11% of fat 
mass and a decrease of 3.8% of lean free-bone tissue mass from a year long 
prospective assessment of the effects of ADT on body composition responses 
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evaluated by dual energy x-ray absorptiometry. Further, the concern related to the 
negative effects of  ADT on accelerating bone loss has been extensively reported in 
the literature (Berruti et al., 2002; Daniell, 2001; Daniell et al., 2000; Diamond, 
Campbell, Bryant, & Lynch, 1998; Diamond, Higano, Smith, Guise, & Singer, 2004; 
Smith, 2002a; Smith et al., 2003; Smith et al., 2001; Stoch et al., 2001; Wei, J. T. et 
al., 1999). As an alternative, resistance exercise studies in older adults have 
consistently shown it to be a safe and effective strategy to counteract sarcopenia 
(Charette et al., 1991b; Fiatarone et al., 1990; Fiatarone et al., 1994; Frontera, 
Meredith, O'Reilly, Knuttgen, & Evans, 1988a; Hakkinen et al., 1998a; McCartney, 
Hicks, Martin, & Webber, 1996b; Nelson et al., 1994; Taaffe, Pruitt, Pyka, Guido, & 
Marcus, 1996) and preserve or induce gains in bone mineral density (Kerr, Morton, 
Dick, & Prince, 1996; Nelson et al., 1994; Pruitt, Taaffe, & Marcus, 1995; Villareal 
et al., 2003). Recently, Villareal and associates (2003) reported positive effects of a 
nine months resistance training program on bone mineral density in older women 
undertaking hormonal replacement. A meta-analysis undertaken by Wolff and 
colleagues (1999) also proposes that resistance training preserves or reverses bone 
loss of up to 1% per year in both femoral neck and lumbar spine sites for pre-and 
post-menopausal women. Taking into consideration the long-term benefits of this 
exercise modality on bone response, resistance training may have an important role 
on reducing the effect of bone loss rate in prostate cancer men undertaking ADT. 
Moreover, considering that traditionally ADT varies from 2-3 years, but can also 
take up to 20 years (Schroder, 2000), the role of resistance exercise may be even 
more relevant by improving psychological and physiological parameters and 
therefore improving quality of life. 
 In the context of maintaining or increasing lean tissue content in healthy 
elderly and various patient populations in which muscle and bone loss are 
problematic, resistance exercise might be more appropriately termed “anabolic 
exercise”.  It is not surprising therefore that the many cardiovascular exercise 
interventions with cancer patients have produced mixed results as such exercise does 
not provide a strong anabolic effect for muscle and bone and may not elicit the 
changes in endocrine status that are desirable in these patients. 
 It is interesting to note that among the different cancer types, breast cancer 
has been the most common cancer type examined during exercise trials. Out of the 
18 studies undertaken during treatment, nine had used exclusively breast cancer 
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subjects (Kolden et al., 2002; MacVicar, Winningham, & Nickel, 1989; Mock et al., 
1997; Mock et al., 2001; Schwartz, 1999; Schwartz, 2000; Schwartz, Mori, Gao, 
Nail, & King, 2001; Segal et al., 2001; Winningham & MacVicar, 1988; 
Winningham, M. L., M.G. MacVicar, M. Bondoc, J.I. Anderson, & J.P. Minton, 
1989) with three studies including breast cancer plus a mixed of cancer populations 
(Dimeo, Fetscher, Lange, Mertelsmann, & Keul, 1997; Dimeo, Rumberger, & Keul, 
1998; Dimeo, Stieglitz, Novelli-Fischer, Fetscher, & Keul, 1999)  and few other 
experiments using, leukemia, stomach cancer, prostate, colon rectal and a mix 
population of cancer types (Adamsen et al., 2003; Courneya et al., 2003; 
Cunningham, Morris, & Cheney, 1986; Na, Kim, Kim, Ha, & Yoon, 2000; Segal et 
al., 2003). A similar figure can be observed with the experimental trials undertaken 
after cancer treatment where three studies were conducted with breast cancer patients 
(Nieman et al., 1995; Peters, Lotzerich, Niemeier, Schule, & Uhlenbruck, 1994; 
Peters, Lotzerich, Niemeir, Schule, & Uhlenbruck, 1995; Segar et al., 1998), three in 
a mixed cancer population including breast cancer (Dimeo, Tilman et al., 1997; 
Durak & Lilly, 1998; Porock, Kristjanson, Tinnelly, Duke, & Blight, 2000) and two 
in a mixed cancer population not including breast cancer (Durak, Lilly, & 
Hackworth, 1999; Sharkey, Carey, Heise, & Barber, 1993). Therefore, future studies 
aiming to examine the role of exercises in cancer populations should also include 
other cancer types than breast to reveal possible physiological and psychological 
benefits from exercise among other cancer groups.  
 As a secondary purpose of this review we attempted to establish a training 
dose response with this population based on the existing literature. The importance of 
scientific exercise principles has been extensively reported (American College of 
Sports Medicine, 1998a, 1998b; Kraemer et al., 2002; Kraemer & Ratamess, 2004). 
It is well known that manipulation of the training program variables of frequency of 
training, intensity of training, specificity of training and rest period between sets and 
exercise sessions produces clearly differentiated effects on specific physiological 
adaptations for both cardiovascular and resistance exercise. Nevertheless, long-term 
trials comparing different training models are rare even in healthy adult populations 
as reported by the American College of Sports Medicine position stand on the 
recommended quantity and quality of exercise prescription in healthy adults 
(American College of Sports Medicine, 1998b). Therefore, most of the studies 
presented in this review which aim to elucidate training response for cancer patients 
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during and after treatment, were short in duration (Adamsen et al., 2003; 
Cunningham, Morris, & Cheney, 1986; Dimeo, Rumberger, & Keul, 1998; Dimeo et 
al., 2003; Dimeo, Tilman et al., 1997; Durak & Lilly, 1998; MacVicar, Winningham, 
& Nickel, 1989; Na, Kim, Kim, Ha, & Yoon, 2000; Nieman et al., 1995; Porock, 
Kristjanson, Tinnelly, Duke, & Blight, 2000; Schwartz, 1999; Schwartz, 2000; 
Schwartz, Mori, Gao, Nail, & King, 2001; Segal et al., 2003; Segar et al., 1998; 
Winningham & MacVicar, 1988; Winningham, M. L., M. G. MacVicar, M. Bondoc, 
J. I. Anderson, & J. P. Minton, 1989) with some interventions still not controlling 
elementary training variables (Durak & Lilly, 1998; Durak, Lilly, & Hackworth, 
1999; Kolden et al., 2002; Mock, 2001b; Porock, Kristjanson, Tinnelly, Duke, & 
Blight, 2000). The short-term nature of these interventions would likely limit the 
ability to detect specific physiological responses with training. Moreover, 
considering that exercise has been endorsed as a crucial component of a healthy 
lifestyle and is viewed as a lifelong behaviour which may prevent and control various 
disease conditions (Pate et al., 1995; Thompson et al., 2003; Wei, Gibbons, Kampert, 
Nichaman, & Blair, 2000; Wei, M. et al., 1999), further studies undertaken for longer 
periods of time are needed. Additionally, the specific training dose for this 
population and how it would differentiate from many of the cancer types, treatments 
modalities and stages of treatment remains an open area for prospective trials. 
Despite the work by Segal and colleagues (2001) and Cunningham and associates 
(1986) which compared a home based vs. supervised exercise and five- vs. three 
times weekly resistance exercises, respectively, none of these studies had actually 
used more than one training protocol, attempting to compare differences in training 
response due to various intensities, frequencies, volume and type of training. 
Consequently, a requirement for future studies on this topic should include 
randomized controlled trials comparing how various types of cancer undergoing 
different treatments and stages of the disease would respond to different training 
stimuli. 
 Finally, the majority of the studies involving resistance training did not draw 
on the wealth of scientific research which has been published in regard to resistance 
training for muscle hypertrophy and strength gain. In all cases excepted one 
(Adamsen et al., 2003) the intensity of exercise in particular was inferior to the 6-10 
RM load that has been deemed optimal for muscle growth and strength enhancement 
(Kraemer et al., 2002; Kraemer & Ratamess, 2004). One of the better designed 
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resistance training interventions addressed in this review was by Cunningham and 
associates (1986) and yet their model was based on research completed around 1950 
(Delorme & Watkins, 1948; Delorme, West, & Shriber, 1950). Moreover, the only 
study which incorporated a better-quality training intensity limited the program to 6-
weeks and performed no more than three resistance exercises (Adamsen et al., 2003).  
Although much more research is required in this important area some guidelines and 
possible physiological outcomes are provided in Table III.  Future research into 
exercise interventions with cancer patients should involve contemporary resistance 
training program designs incorporating adequate intensity, periodization, selection of 
functional exercises involving large muscle groups, and manipulation of rest period 
and recovery strategies to maximize the anabolic effect on muscle and bone, as well 
as positive endocrine responses.       
Table I. Experimental design exercise studies during cancer treatment. 
 
Study Duration/ 
Freq. 
n/ sex/ age Type of cancer Exercise program Intensity Outcome measures 
Cunningham  
et al 1986 
(49) 
5 weeks 
3-5 x week 
 
40, M, W 
(14-44 y) 
 
Leukemia Resistance training Unspecified  
↓ Nitrogen balance 
↔ Creatinine excretion 
↔ AC 
Winningham  
et al. 1988 
(50) 
 
12 weeks 
3 x week 
 
42, W  
(45-48 y) 
 
Breast Cardiovascular 
Cycling IT 
20-30 minutes  
 
60-85% MHR ↓ Nausea 
Winningham  
et al. 1989 
(48) 
12 weeks 
3 x week 
 
24, W 
(45 y) 
 
Breast Cardiovascular 
Cycling IT 
20-30 minutes 
 
60-85% MHR ↑ Lean tissue mass 
↓ 0.5% Body fat 
↓  Skinfold sites 
Macvicar  
et al. 1989 
(30) 
10 weeks 
3 x week 
45, W 
(43-46 y) 
 
Breast Cardiovascular 
Cycling IT 
60-85% MHR ↑ 42% VO2max 
 
Mock  
et al. 1997 
(23) 
6 weeks 
4-5 x week 
 
46, W 
(35-64 y) 
 
Breast Cardiovascular 
Walking 
20-30 minutes 
Self-paced ↑ 4% 12-MWT 
↓ Fatigue 
↓ Symptom experience 
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Dimeo 
et al. 1997 
(29) 
~ 2 weeks 
Daily 
 
70, M, W 
 (39-40 y) 
 
Breast, Sarcoma 
Carcinoma 
Adenocarcinoma 
Neuroblastoma 
Cardiovascular 
Cycling IT 
30 minutes 
50% HRR ↓ 14% MP, ↓ Thro 
↓ Neutro, ↓ Hosp 
Dimeo  
et al. 1998 
(22) 
6 weeks 
5 x week 
 
5, M, W 
(18-55 y)  
 
Hodgkin’s lymp.  
Non-Hodgkin’s lymp.  
Bronchial, Breast 
Medulloblastoma 
Progressive 
treadmill Walking 
30-35 minutes 
3 mmol.L (LC) 
80% MHR 
↓ 100% LC 
↓ 18%  Heart rate 
↑ 101 % TD 
↑ 12 % MP 
Dimeo 
 et al. 1999 
(35) 
* 
Daily 
 
59, M, W 
(40 y) 
 
 Breast, Lung 
Carcinoma, Seminoma 
Adenocarcinoma 
Hodgkin’s lymp. 
 
Cardiovascular 
Cycling IT 
30 minutes 
 
50% HRR ↓ Psychologic distress 
Schwartz et al. 
1999, 2000 
(46, 47) 
8 weeks 
4 x week 
 
27, W 
(35-57 y) 
 
Breast 
 
Cardiovascular 
Walking 
35 minutes 
Self-paced 
Accelerometers 
↑ 10.4% 12-MWT 
↓ Fatigue 
 
Na 
et al. 2000 
(25) 
2 weeks 
5 x week 
 
35, * 
(28-75 y) 
 
Stomach Cardiovascular 
Arms and Cycling 
Ergometers 
30 minutes 
 
60% MHR ↑ 28% NKCA 
Schwartz  
et al. 2001 
(52) 
8 weeks 
3-4 x week 
 
72, W 
 (27-69 y) 
 
Breast 
 
Cardiovascular 
Walking 
12 minutes 
Self-paced 
Accelerometers 
↑ 15% 12-MWT 
↓ Fatigue 
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Mock  
et al. 2001 
(31) 
6-24 weeks 
5-6 x week 
 
52, W 
(28-75 y) 
 
Breast Cardiovascular 
Walking 
10-30 minutes 
Self-paced ↑ 6% 12-MWT 
↓ Fatigue 
↓ Emotional distress 
Segal  
et al. 2001 
(45) 
26 weeks 
5 x week 
 
123, W 
(51.4 y) 
 
Breast Cardiovascular 
Walking 
Home vs. non-
home based 
50-60%  
VO2max 
↑ Physical functioning 
↔ Quality of life 
↔ VO2max 
Kolden  
et al. 2002 
(24) 
16 weeks 
3 x week 
 
40, W 
(45-76 y) 
 
Breast Cardiovascular 
Walking, Cycling, 
Stepping 
Resistance training 
Flexibility 
 
Unspecified ↑ 11% Flexibility 
↑ 15.4% VO2max 
↑ 34.5% UB 
↑37% LB 
↓ 5% RSBP 
↑ Quality of life 
Segal  
et al. 2003 
(32) 
12 weeks 
3 x week 
 
155, M 
(68.2 y) 
 
Prostate Resistance training 
2 sets 
 12 repetitions 
 
60-70% 1-RM ↑ 42% UB 
↑ 36 % LB 
↔ Body composition 
↔ PSA, ↓ Fatigue 
↑ Quality of life 
Dimeo  
et al. 2003 
(26) 
~ 2 weeks 
Daily 
 
66, M, W 
(20-73 y) 
 
Leukemia, 
 Hodgkin’s lymp.  
Non-Hodgkin’s lymp.  
Myeloma 
Cardiovascular 
Walking 
70% MHR ↔ Walking speed 
↓ 6.7% HEM 
                                                      Resistance Training in Men Receiving ADT     
 
 31
Courneya  
et al. 2003 
(27) 
16 weeks 
3-5 x week 
 
102, M, W 
(61.1 y) 
 
Colorectal Cardiovascular 
Walking 
Flexibility 
65-75% MHR 
 
↔ Quality of life 
↔ Cardiovascular 
capacity 
Adamsen 
 et al. 2003 
(28) 
6 weeks 
4 x week 
 
23, M, W 
(18-63 y) 
 
Leukemia , Breast 
Colon, Ovary 
Testis, Cervix 
Hodgkin’s lymp.  
Non-Hodgkin’s lymp. 
Resistance training 
3 sets  
 5-8 repetitions 
Cardiovascular 
Cycling 
Relaxation 
60-100% MHR 
85-95% 1-RM 
 
↑ 32.5% WB 
↑ 16% VO2max 
↔ Quality of life 
 
 
↔ = no change, ↑ = increase, ↓ = decrease, W = women, M = men, * = not described, PSA = Prostate-specific antigen, LC = Lactate 
concentration, VO2max = VO2 maximum, IT = Interval training, TD = Training distance, MHR = Maximum heart rate, MP = Maximal 
performance (MET), HEM = Hemoglobin, AC = Arm circumference, UB = Upper body strength, LB= Lower body strength, WB = Whole 
body strength, RSBP = Resting Systolic Blood Pressure, NKCA = Natural killer cell cytotoxic activity, HRR = Heart rate reserve,  
Neutro = duration of neutropenia, Thro = duration of thrombopenia, Hosp = duration of hospitalization. 
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Table II. Experimental design exercise studies after cancer treatment. 
 
Study Duration/ 
Freq. 
n/ sex/age Type of cancer Exercise program Intensity Outcome measures 
Sharkey 
 et al. 1993 
(38) 
12 weeks 
2 x week 
10, M, W 
(19 y)  
 
Leukemia 
 Ewings Tumor 
Neuroblastoma    
Wilms’ Tumor 
Rhabdomyosarcoma 
Cardiovascular 
* 
 
60-80% MHR 10% ET, ↔ AT 
↔ Peak OX 
↔ Peak HR 
 
Peters et al. 
1994, 1995 
(39, 40) 
28 weeks 
2-5 x week 
 
24 ,W 
(49 y) 
 
Breast Cardiovascular 
Cycling 
 
~ 60% MHR ↑↓ Satisfaction of life 
↔ NKCA             
↔ Leukocytes 
↓ 2.1 % Lymphocytes 
↓ 1.1% Monocytes  
↑ 4.1% Granulocytes 
 
Nieman  
et al. 1995 
(43) 
8 weeks 
3 x week 
12, W 
(61 y) 
Breast Cardiovascular 
Resistance raining 
75% MHR ↔ NKCA 
↔ LB 
↑ 6-minute Walk Test 
Dimeo  
et al. 1997 
(36) 
6 weeks 
5 x week 
 
36, M, W 
(39-42 y) 
 
Non-Hodgkin’s lymp.  
Breast, Sarcoma  
Seminoma, Lung  
Cardiovascular 
Walking 
 30 minutes 
3 mmol.L 
(LC) 
 
↑ 32% MP 
 ↑ 30% HEM 
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Segar  
et al. 1998 
(44) 
10 weeks 
4 x week 
24, W 
(30-65 y) 
 
Breast Cardiovascular 
30-40 minutes 
≥ 60% MHR ↓ Depression  
↓ Anxiety 
Durak  
et al. 1998 
(41) 
10 weeks 
2 week 
20, M, W 
(50 y) 
 
Carcinoma, 
Lymphoma 
Leukemia 
Cardiovascular 
Resistance training 
Flexibility 
Own RPE ↑ 43% WB, 41.4%↑ 
MP 
↑ Quality of life 
Durak  
et al. 1999 
(42) 
20 weeks 
2 x week 
25, M, W 
 (44-71 y) 
 
Prostate 
Carcinoma 
Leukemia 
Cardiovascular 
Resistance training 
Unspecified ↔ Aerobic capacity 
↑ 45% WB 
Porock  
et al. 2000 
(37) 
4 weeks 
* 
9, M, W 
(51-77 y) 
 
Bowel, Breast, Oral, 
Pancreas, Melanoma 
Cardiovascular 
Resistance training 
Unspecified ↓ Depression ↓ Anxiety 
↔ Fatigue 
 
↔ = no change, ↑ = increase, ↓ = decrease, ↑↓ = increased at week 5 and decreased at post test, * = not described, M = men, W = women, 
LC = Lactate concentration, MHR = Maximum heart rate, MP = Maximal performance (MET), HEM = Hemoglobin, LB = Lower body 
strength, WB = Whole body Strength, NKCA = Natural killer cell cytotoxic activity, ET = Exercise tolerance, AT = Anaerobic threshold, 
Peak OX = Peak oxygen uptake, Peak HR = Peak heart rate.  
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Table III. Guidelines and possible physiological outcomes from exercise in cancer patients 
 
 
↑ = increase, ↓ = decrease, ↔ = maintain, MHR =maximum heart rate, MHRR = maximum heart rate reserve, HDL = high-density 
lipoprotein, LDL = low-density lipoprotein, BMD = bone mineral density, FP = functional performance, RM = repetition maximum 
* Data not available with cancer population, recommendation based from studies undertaken with non-cancer population.  
Exercise Modality Intensity Frequency Volume/ Dosage Cancer Relevant Expected Outcomes 
 
Cardiovascular 
Exercises 
 
55-90% MHR 
40-85% MHRR 
 
3-5 x per week 
 
20-60 minutes 
continuous or intermittent  
 
↑ Cardiopulmonary function 
↑ Insulin sensitivity*, ↑ HDL*, ↓ LDL* 
↓ Fat mass, ↓ Fatigue 
 
Anabolic/Resistance 
Exercises 
50-80% 1-RM 
6-12RM 
1-3 x per week 1-4 Sets per muscle group ↑ Muscle mass*, ↑ Muscle strength 
↑ Muscle power*, ↑ Muscle endurance 
↑ BMD*, ↑ FP, ↓ Fatigue 
↑ Resting metabolic rate*, ↓ Fat mass* 
Flexibility 
Exercises 
? 2-3 x per week 2-4 Sets per muscle group 
10-30 seconds 
↑ ↔ Range of motion 
Chapter 3 
REVIEW OF LITERATURE TWO 
 
 
 
ANABOLIC RESPONSES TO RESISTANCE TRAINING 
IN OLDER MEN AND WOMEN: A BRIEF REVIEW 
 
 
 
Daniel A. Galvão, Robert U. Newton & Dennis R. Taaffe.  
Journal of Aging and Physical Activity. 13:343-358, 2005. 
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Introduction   
 
 
 Normal aging is characterized by a decline in skeletal muscle mass and an 
increase in fat mass (Frontera et al., 2000; Fukagawa, Bandini, & Young, 1990; 
Lexell, 1995). The reduction in muscle mass, termed sarcopenia, leads to a loss in 
muscle strength and is associated with a decline in physical function that 
compromises independent living (Rosenberg, 1997). However, numerous studies 
have shown resistance training to be a safe and effective intervention to counteract 
sarcopenia, even in very old persons, that is, those aged 85 years and older (Charette 
et al., 1991a; Fiatarone et al., 1990; Fiatarone et al., 1994; Taaffe, Duret, Wheeler, & 
Marcus, 1999; Taaffe, Pruitt, Pyka, Guido, & Marcus, 1996).  
 The landmark study in 1988 by Frontera and colleagues (Frontera, Meredith, 
O'Reilly, Knuttgen, & Evans, 1988b), using computed tomography scanning of the 
mid-thigh and muscle tissue samples, clearly showed the residual capacity that older 
adults have to increase muscle cross-sectional area (CSA) with an increase in 
midthigh total muscle area of 11.4% and an increase in type I and II fiber area of 
33.5% and 27.6%, respectively, following 12 weeks strength training. Subsequently, 
numerous studies  have reported positive changes in muscle CSA, muscle fiber size, 
and body composition following resistance training interventions (Charette et al., 
1991a; Fiatarone et al., 1990; Fiatarone et al., 1994; McCartney, Hicks, Martin, & 
Webber, 1996a; Taaffe, Duret, Wheeler, & Marcus, 1999; Taaffe, Pruitt, Pyka, 
Guido, & Marcus, 1996). Less clear is the effect of age and sex on the anabolic 
response to resistive exercise.  
 In studies directly comparing anabolic responses  between young and older 
adults to resistance exercise, older adults retain the ability to adapt in a relatively 
similar fashion to their younger counterparts  (Hakkinen et al., 1998a; Ivey et al., 
2000; Lemmer et al., 2000; Roth et al., 2001), although this has not always been 
reported (Welle, Totterman, & Thornton, 1996). Within young adults, the majority of 
studies  (Abe, DeHoyos, Pollock, & Garzarella, 2000; Cureton, Collins, Hill, & 
McElhannon, 1988; Hurlbut et al., 2002; Lemmer et al., 2000; Lemmer et al., 2001; 
O'Hagan, Sale, MacDougall, & Garner, 1995; Roth et al., 2001; Staron et al., 1994) 
indicate that men and women experience similar relative changes in fat-free mass, 
muscle CSA and fiber CSA after training, though others (Ivey et al., 2000) have 
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reported a greater response in men.  In older adults (> 60 years), some investigations 
have demonstrated similar relative strength gains and body composition changes 
between men and women following training (Fiatarone et al., 1994; Ivey et al., 2000; 
Lexell, 1995; McCartney, Hicks, Martin, & Webber, 1995, 1996a; Roth et al., 2001; 
Tracy et al., 1999) while others indicate the presence of sex differences as 
determined by single muscle fiber contractile function (Trappe et al., 2001), fiber 
diameter (Bamman et al., 2003; Hakkinen et al., 2002) and muscle CSA (Hakkinen et 
al., 1998b). It has been suggested that differences in anabolic hormones and the 
myostatin genotype may contribute to these sex differences (Bamman et al., 2003; 
Ivey et al., 2000).    
 Given the increased recognition of sarcopenia in the medical and allied health 
community, and the recommendation by professional bodies for older adults to 
undertake resistance exercise (American College of Sports Medicine, 1998b), the 
effects of training in the older adult need to be clearly delineated, including any 
differences by sex. Women are  more susceptible to falling below the strength 
thresholds required for daily activities and are subject to longer periods of 
compromised function than men due to their greater longevity (Ivey et al., 2000). As 
a result, if sex differences exist in the response to a given exercise stimulus, then this 
needs to be determined so that the most appropriate exercise programs can be 
devised. Therefore, the purpose of this paper is to present an overview of studies that 
have undertaken measures of body composition, muscle and fiber CSA adaptations 
to resistance training in older men and women who perform the same intervention. In 
addition, we briefly discuss studies that include only older men or women to provide 
a more comprehensive overview of the topic. Due to differences in tissue and body 
composition techniques, this brief review is divided into seven sub-sections: 
computed tomography, dual energy x-ray absorptiometry, magnetic resonance 
imaging, compound ultrasound, the BOD POD, muscle biopsy, and myosin heavy 
chain analysis.   
Training Studies by Assessment Technique 
 
An overview in chronological order of the studies directly comparing men and 
women undertaking the same training intervention is provided in the accompanying 
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table.  Apart from the anabolic response, which is discussed below, the effect of the 
intervention on body weight and muscle strength is also provided for the reader. 
Computed Tomography (CT) 
 
 Computed tomography uses multiple x-rays and computers to reconstruct 
images of the target area and generate quantitative information of muscle area, 
subcutaneous and intermuscular fat area, and attenuation of the tissue as determined 
by Hounsfield units (Lee, Wang, & Heymsfield, 2001; Mitsiopoulos et al., 1998; 
Sipila & Suominen, 1993). McCartney et al. (1995) examined the effect of resistance 
exercise on muscle CSA assessed by CT in men and women (60 to 80 years) 
following 10 months training (Table). Subjects were randomly allocated to an 
exercise or control group and performed the unilateral leg press, ankle plantar 
flexion, ankle dorsi flexion, as well as several upper body exercises. Similar CSA 
adaptation of the knee extensor muscles for men (6.2 %) and women (4.7 %) was 
observed and both percentage changes were significantly greater than controls. In a 
subsequent report following two years of training (McCartney et al., 1996), CSA of 
the knee extensors for both men and women continued to increase, although not at 
the same rate as that in the first year of the study. 
Dual Energy X-ray Absorptiometry (DXA) 
 
 Dual energy x-ray absorptiometry estimates fat-mass, bone mineral-free lean 
mass and bone mineral mass using two distinct low-energy x-rays that penetrate the 
soft tissue and bone areas, and has been demonstrated to be an accurate and precise 
method of body/tissue composition compared to reference methods such as total 
body potassium, hydrodensitometry, magnetic resonance imaging (MRI), CT, and 
four-component models (Haarbo, Gotfredsen, Hassager, & Christiansen, 1991; 
Kohrt, 1998; Prior et al., 1997; Shih, Wang, Heo, Wang, & Heymsfield, 2000; 
Visser, Fuerst, Lang, Salamone, & Harris, 1999). Body composition response to 
resistance training assessed by DXA in older men and women was reported by 
Martel et al. (1999). Subjects (65 to 73 years) trained three days per week for 24 
weeks performing several upper and lower body exercises. There were no significant 
differences as a result of resistance training in either sex for fat-free mass or body fat. 
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When men and women were combined, a significant increase was detected for fat-
free mass (p < 0.05).   
  Lemmer et al. (2000) reported the effect of a training regimen that 
incorporated five sets of five repetitions maximum of unilateral leg extension 
exercise of the dominant leg for nine weeks on strength and body composition in 
older men and women. There was no significant change in body fat and fat-free 
mass. Although the aim of the study was primarily designed to detect sex-related 
changes on muscle strength with training and detraining, results from the body 
composition changes are limited due to the fact that only the quadriceps muscle 
group was trained. The same group of investigators (Lemmer et al., 2001) also 
examined the effect of age and sex following 24 weeks resistance training. Eleven 
men and 10 women (65 to 75 years) trained three days per week utilizing unilateral 
leg press, leg curl, leg extension, chest press, lat pull down, military press, upper 
back, triceps extension and unilateral biceps curl exercises. Men and women 
significantly increased fat-free mass from baseline to week 24 (p < 0.05), with no 
significant difference by sex.  
 Hurlbut et al.(2002) examined the effect of resistance training by age, sex and 
angiotensin I-converting enzyme (ACE) genotype on fasting and glucose-stimulated 
glucose and insulin response. Twelve men and nine women (65 to 75 years) 
exercised thrice weekly over 24 weeks. The training routine consisted of three lower 
body exercises, six upper body exercises and two trunk exercises. Following training, 
men increased fat-free mass by 1.5 % (p < 0.05) and women by 2.2 % which 
approached statistical significance (p = 0.06). There were no significant changes in 
fat mass for either group.  
 Recently, Ryan et al. (2004) reported the results from a 24-week whole body 
resistance training program on body composition in older men and women. There 
was no significant change in fat-free mass for older women (1.7 %) whereas the 
increase for older men (1.6 %) reached statistical significance (p < 0.05). No changes 
were observed for body fat in either group. In addition, both men (24.2 %) and 
women (20.8 %) similarly increased whole body muscle strength (p < 0.001), which 
is the average strength for the exercises/muscle groups examined. Interestingly, 
while percentage change in these studies (Hurlbut et al., 2002; Ryan et al., 2004) for 
fat-free mass was similar between men and women, the latter group did not achieve 
statistical significance perhaps indicating a greater within-group variance. That is, 
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women may not demonstrate as consistent a change in response to resistance training 
as men. 
Magnetic Resonance Imaging (MRI) 
 
 In contrast to CT and DXA which employs ionizing radiation, MRI uses 
magnetic energy and radio waves to derive images of a target tissue area and has 
been found to be an accurate method for assessing tissue composition (Lee et al., 
2000; Lee, Wang, & Heymsfield, 2001; Mitsiopoulos et al., 1998). The effect of 
resistance training on muscle volume assessed by MRI has been reported by Ivey et 
al. (1999) and Tracy et al. (2000). Men and women (65 to 75 years) participated in a 
resistance training intervention performing unilateral knee extension of the dominant 
leg three times per week for nine weeks while the opposite leg served as the control. 
Muscle volume change was similar for both men (11.5 %) and women (12 %), with 
no change in whole body fat-free or fat mass assessed by DXA.  The lack of change 
in fat-free or fat mass assessed by DXA was not surprising given that only one 
muscle group was trained.  
 Roth and colleagues (2001) examined sex differences in thigh muscle volume 
response after resistance training in subjects aged 65 to 75 years. Nine men and 10 
women performed unilateral leg press, unilateral leg curl, unilateral leg extension, 
chest press, lat pull down, overhead shoulder press, upper back rowing, triceps 
extension, and unilateral biceps curl exercises thrice weekly for 24 weeks. Both 
groups demonstrated a significant increase in fat-free mass (p < 0.05) but not for 
percentage of body fat assessed by DXA. MRI results indicated that both men (4.1 
%) and women (5.8 %) increased (p < 0.01) estimated whole thigh muscle volume 
with no significant difference between groups. Similarly, men (1.6 %) and women 
(5.6 %) experienced a significant increase in mid-thigh muscle CSA (p < 0.01), 
although the difference between sexes was not statistically significant.  
Compound Ultrasonic Scanner (CUS) 
 
 Compound ultrasonic scanner uses acoustic impedance properties of the 
body’s tissues to form an image from which muscle tissue can be separated from 
bone and fat tissue (Sipila & Suominen, 1993). Hakkinen and colleagues (1998b) 
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investigated muscle strength, body composition and knee extensor cross-sectional 
area by CUS of men and women (67 to 72 years) following 24 weeks of resistance 
training. The program consisted of a combination of heavy resistance and explosive 
training. Although percentage of body fat assessed by skinfolds did not change 
during the course of the intervention, muscle CSA of the leg extensors increased by 
5.8 % in women (p < 0.05) with no significant change for men (2.1 %). 
BOD POD 
 
 The BOD POD estimates body composition by measuring the volume of air 
an individual displaces inside an enclosed chamber and has been shown to be a valid 
technique to estimate body composition (Fields, Goran, & McCrory, 2002; Fields, 
Hunter, & Goran, 2000).  Hunter and associates (2002) used a BOD POD to examine 
the body composition response in older men and women after 25 weeks of resistance 
training. Subjects performed five upper body exercises, two lower body exercises 
and two trunk exercises three times per week during the intervention. Body fat 
decreased (> 2 %) similarly and significantly for men and women (p < 0.05), while 
the alterations in fat-free mass between men (4.7 %) and women (2.3 %) approached 
significance (p = 0.06).  
Muscle Biopsy 
 
 Muscle biopsy is a procedure in which muscle samples are extracted by the 
needle technique, frozen and stored for histochemical analysis (Taaffe, Pruitt, Pyka, 
Guido, & Marcus, 1996). The effect of resistance training on muscle strength and 
type I and II muscle fiber CSA for the biceps brachii and the vastus lateralis muscles 
of men and women (70 to 77 years) was examined by Lexell et al. (Lexell, 
Downham, Larsson, Bruhn, & Morsing, 1995). Comparable mean gains in biceps 
brachii type II CSA were found in men (17 %) and women (16 %), respectively. 
However, this was not statistically significant in men due to the large inter-individual 
variation. For the vastus lateralis muscle, there was no significant change in type I 
and II CSA. However, type II CSA for men surprisingly decreased by 14 %. 
 Hakkinen and colleagues (2002) examined the effects of strength/power 
training over 24 weeks on muscle fibre distribution and areas of type I, IIa and IIb 
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CSA of the vastus lateralis in older men and women (60 to 75 years). Type I, IIa, and 
IIb fiber area significantly increased by 50.6 %, 48.4 %, and 46.2 %, respectively, in 
men with smaller, yet significant, changes in women of 28.6 % for type I and 33.2 % 
for type IIa muscle fibers. However, the change in type IIb CSA for women of 18.9 
% was not statistically significant. When comparing the results for these two groups, 
this study demonstrated older men and women had the capacity to significantly 
increase fiber CSA, with greater adaptations in men.  
 Bamman and associates (2003) reported the effects of 26 weeks of resistance 
training on muscle fiber CSA and myosin heavy chain composition in nine men and 
five women (61 to 77 years). Men and women similarly increased fat-free mass by 
4.4 % and 4.2 %, respectively, and decreased body fat by 2.9 % and 3.1 %  (p < 0.05) 
as assessed by the BOD POD, with no significant difference by sex. However, results 
from muscle biopsies indicated that men significantly increased muscle fiber type I, 
IIa and IIx CSA by 29 %, 41 % and 43 % while women increased by only 6.5 %, 5.7 
% and 5 %, respectively, indicating significant differences between the sexes. It is 
important to note that only five women took part in the study and the number of 
fibers analyzed was not reported. In addition, it is unclear if the investigators were 
blinded to sex in the analysis. For clarification purposes, human type IIb fibers have 
been shown to be homologous to the type IIx in the rat, therefore IIx is commonly 
used for classification of this fiber type (Smerdu, Karsch-Mizrachi, Campione, 
Leinwand, & Schiaffino, 1994). Apart from the small number of women taking part 
in this study, it is possible that fiber size of the vastus lateralis muscle does not 
reflect changes in other muscles following exercise (Frontera, Meredith, O'Reilly, 
Knuttgen, & Evans, 1988b; Narici, Roi, Landoni, Minetti, & Cerretelli, 1989) and 
sex differences in hypertrophy of other muscle groups could contribute to the similar 
increase in whole body fat-free mass observed by Bamman et al. (2003). 
Myosin Heavy Chain Expression (MHC) 
 
 Myosin heavy chain composition is analysed using a muscle sample extracted 
using the muscle biopsy procedure followed by gel electrophoresis techniques for 
protein separation (Frontera, Meredith, O'Reilly, Knuttgen, & Evans, 1988b; 
Schiaffino et al., 1989). In addition, single muscle fibers may be isolated and the 
characteristics both in terms of function and diameter. Such analysis has been 
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completed by Trappe and associates (2001; Trappe et al., 2000) involving older men 
and women following a resistance training program. In their first report (Trappe et 
al., 2000), results from a 12-week leg extension program undertaken by older men 
resulted in an increase (p < 0.05) of 20.4 and 12.7 % in the fiber diameter expressed 
by MHC I and MHC IIa, respectively. Subsequently, the same group of investigators 
reported the results from an identical training protocol, but on this occasion 
undertaken by older women (Trappe et al., 2001). The fiber diameter expressed by 
MHC I and MHC IIa increased in older women by 24.4 % (p < 0.05) and 6 %, 
respectively. When the results from fiber diameter expressed by MHC I and MHC 
IIa were compared, no sex differences were observed.  However, single muscle fiber 
function, expressed by absolute power and maximum shortening velocity, was 
significantly greater in older men than women (p < 0.05). The authors suggested that 
older men and women respond differently at the muscle cell level when the same 
training stimulus is applied.  
 
Discussion 
 
 As resistance training becomes increasingly recognized as an effective 
countermeasure to sarcopenia in the medical community, and as more older adults 
embark in these training regimens, the training responses including possible sex 
differences need to be clearly identified. Moreover, from a research perspective, if 
men and women attain similar relative anabolic and muscle strength changes to 
training, then it is possible to combine both sexes in the same sample in exercise 
trials to increase statistical power and/or facilitate subject recruitment.   
 Since the findings by Frontera and colleagues (1988b), which clearly refuted  
Moritani & de Vries (1980) earlier report of a lack of soft-tissue change in response 
to training in older men, numerous studies have demonstrated the residual capacity of 
older adults to increase muscle and fiber cross-sectional area following resistance 
training. Advances in the assessment of body and muscle composition by MRI, CT, 
DXA and histochemistry over the past two decades have increased the ability to 
detect subtle changes that were previously not possible. 
 Although studies directly comparing older women and men in their anabolic 
adaptations to resistance training are somewhat limited (e.g., Bamman et al., 2003; 
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Hakkinen et al., 2001; Lemmer et al., 2001; Roth et al., 2001), numerous studies 
examined the effect of resistance training on fat-free mass, muscle and fiber area of 
women and men undertaking different interventions (e.g. Charette et al., 1991; 
Frontera et al., 1988; Taaffe et al., 1996) supporting the high level of adaptability 
remaining in aging skeletal muscle. 
 The only study to date directly comparing muscle area in older men and 
women by CT reported similar adaptations for the knee extensors of 6.2 % and 4.7 
%, respectively (McCartney, Hicks, Martin, & Webber, 1995). The results for older 
men are in agreement with results reported previously by the same laboratory 
(Brown, McCartney, & Sale, 1990), where older men increased (p < 0.01) knee 
extensor muscle CSA by 9.9% after 12 weeks of resistance training. Similarly, 
Frontera et al. (1988b) reported comparable increases in knee extensor CSA in older 
men assessed by CT (9.3 %) after 12 weeks training and Ferri and associates (2003) 
reported an increase of 7.4 % in knee extensor muscle CSA following 16 weeks of 
resistance training. Muscle CSA response to resistance training in older women has 
been assessed by Sipila & Suominen (1995) using CT, with increases in knee 
extensor CSA of 4.9 % after 18 weeks exercise, similar to those detected by 
McCartney and colleagues (1995).  
 Studies directly comparing fat-free mass and fat mass by DXA (Hurlbut et 
al., 2002; Ivey et al., 2000; Lemmer et al., 2000; Lemmer et al., 2001; Martel et al., 
1999; Roth et al., 2001; Tracy et al., 1999) following resistance training do not 
support significant sex differences except for the study by Hurlbut and associates 
(2002). It is important to point out that change in fat-free mass and fat mass were not 
the main outcomes for these studies. As such, it is not expected that changes in body 
composition will be detected with only one exercise even in a long-term intervention. 
In such cases, sub-regional analysis of the DXA scan may have been a more sensitive 
technique to detect local changes in tissue composition. In addition, the anabolic 
effect of such isolated interventions is considerably compromised because the 
endocrine responses favouring muscle hypertrophy will not be produced. For 
example, elevation of testosterone and growth hormone with resistance training is 
closely related to the volume of muscle activated (Hakkinen & Pakarinen, 1993; 
Hakkinen, Pakarinen, Kraemer, Newton, & Alen, 2000; Kraemer et al., 1999a). In 
contrast, Nichols and colleagues (1993) reported a significant increase in fat-free 
mass of 3.6 % for older women in response to 24 weeks of whole body exercise. The 
  46
percentage changes are comparable with those reported by Lemmer et al. (2001) of 
2.1 % and Martel et al. (1999) of 2.4 % in women after the same duration and 
frequency of training, although the changes observed by Martel et al. (1999) were not 
statistically significant.  
  Several studies have compared men and women for muscle fiber CSA 
adaptations to the same resistance training program.  Interestingly, there are 
conflicting findings among them. Lexell and colleagues (1995) reported similar 
changes in men and women for the biceps brachii while Bamman and associates 
(2003) demonstrated substantial increases in men with less magnitude changes in 
women for the vastus lateralis muscle. Hakkinen et al. (2002) also reported that 
relative hypertrophy was two-fold higher in type I and IIb fiber CSA for the vastus 
lateralis muscle in men compared to women.  
 Comparing these two gender studies with those involving men or women 
only also reveals conflicting outcomes.  For example, the magnitude of change 
observed in men by Bamman and associates is in agreement with Frontera et al. 
(1988) who reported a 33.5 % and 27.6 % increase in type I and type II fiber cross-
sectional area in men. However, Brown and colleagues (1990) reported substantial 
increases in both type I (13.7 %) and type II (30 %) biceps brachii muscle fiber CSA 
in older men similar to Hakkinen and associates (2001) for the vastus lateralis muscle 
in women (type I, 18 %; type IIa, 27.7 %; type IIb, 38 %) following 21 weeks 
training. In addition, Charette et al. (1991a) reported an increase of 7.3 % and 20.1 % 
for type I and II fiber CSA, respectively, after 12 weeks training, while Taaffe and 
colleagues (1996) reported comparable increases in type I (27.5 %) and type II CSA 
(22.1 %) following 52 weeks training in women.   
 The relatively small sample size in most of the studies presented in this 
review likely limit the ability to detect statistically significant differences between 
men and women and should be considered when interpreting the results from these 
experiments. Moreover, large inter-individual variation to identical training protocols 
increases the standard deviation of the samples and reduces the statistical power to 
detect a difference if one exists. Some of the studies presented (Hunter, Bryan, 
Wetzstein, Zuckerman, & Bamman, 2002; Martel et al., 1999; Roth et al., 2001; 
Trappe et al., 2001) have a two-fold or greater increase in anabolic response between 
men and women, yet are not significantly different. However, differences of this 
magnitude may be clinically important. Therefore, clinical/practical versus statistical 
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significance must be considered.  Moreover, numerous studies presented in this 
review were not specifically designed to examine anabolic differences by sex, having 
such outcomes only as a secondary endpoint of the intervention. Thus, considering 
the design limitations and differences in anabolic measurement techniques used in 
previous studies, future research should incorporate larger sample sizes with multiple 
measurement time points for anabolic responses. 
 In summary, the majority of studies directly examining anabolic responses to 
resistance training in older men and women support comparable adaptations 
following 9 to 42 weeks of exercise with similar relative increases in muscle 
strength. However, two recent studies indicate that men may exhibit a greater 
adaptation than women at the muscle cell level when undertaking the same training 
program (Bamman et al., 2003; Hakkinen et al., 2002). Although, superior changes 
in fiber CSA may occur in men, only the study by Bamman et al. (2003) indicates 
that these anabolic changes translate into greater relative improvements in muscle 
strength. Therefore, based on the studies conducted to date, it appears appropriate to 
include older men and women in the same exercise regimen as the anabolic and 
muscle strength response is relatively similar.
Table. Older men vs. women anabolic response to resistance exercise.  
Study Duration/ 
Freq./  
Sets/ Rep./ 
Intensity  
Subjects  
(Sex, n, age)    
Metho
d 
Tissue/ Body Composition  
% Change 
Body 
Weight  
% 
Change 
Strength 
% Change 
Sex 
Differenc
e 
 
Lexell et al. 
1995 
 
11 weeks 
 3 x week 
3 sets/ 6 rep 
85% 1RM 
 
M (n = 6) 
70-77y 
W (n = 10) 
70-77y 
 
Biopsy 
 
(BB) TI 13.0, TII 17.0 
(VL) TI - 1.0,  TII - 14.0 * 
(BB) TI 13.0, TII 16.0 * 
(VL) TI - 8.0, TII 1.0  
 
n.r. 
 
n.r. 
 
107.0 WB * 
 
104.0 WB * 
 
M = W 
McCartney  
et al. 1995 
42 weeks 
 2 x week 
2-3 sets 
10-12 rep 
50-80% 
1RM 
M (n = 39) 
60-80y 
W (n = 37) 
60-80y 
 
CT CSA (QF) 6.2 * 
 
CSA (QF) 4.7 * 
n.r. 
 
n.r. 
36.7 WB ♦ * 
 
46.2 WB ♦ * 
M = W 
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Hakkinen  
et al. 1998 
24 weeks 
2 x week 
3-6 sets 
3-15 rep 
50-80% 
1RM 
M (n = 11) 
72y 
W (n = 10) 
67y 
 
CUS, S B.f. - 1.0, CSA (QF) 2.1 
 
B.f.  n.c., CSA (QF) 5.8 * 
n.c. 
 
n.c. 
21.3 LB * 
 
30.0 LB * 
W > M 
Tracy et al. 
1999 
9 weeks 
3 x week 
5 sets/5RM 
M (n = 12) 
65-75y 
W (n = 11) 
65-73y 
MRI  
DXA 
B.f.  n.c., CSA (QF) 11.5 * 
 
B.f. - 0.7, CSA (QF) 12.0 * 
0.9 
 
- 0.2 
27.0 LB * 
 
29.0 LB * 
M = W 
Martel et al. 
1999 
24 weeks 
 3 x weeks 
1-2 sets/ 
5RM 
M ( n = 11) 
65-73y 
W ( n = 10) 
65-73y 
DXA B.f. - 1.0, F.f.m. n.c. 
 
B.f.  - 1.0, F.f.m. 2.4 
2.4 
 
(n.c) 
21.9 WB * 
 
23.9 WB * 
M = W 
Ivey et al. 
2000 
9 weeks 
3 x week 
5 sets/ 5RM 
M (n = 12) 
65-75y 
W (n = 11) 
65-75y 
MRI  
DXA 
B.f.  n.c., F.f.m. 0.7 
MV (thigh) 11.5 * 
B.f. - 0.7, F.f.m. -1.8 
MV (thigh) 12.0 * 
 
0.9 * 
 
- 0.2 
n.r. 
 
n.r. 
M = W 
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Trappe et 
al. 
2000, 2001 
12 weeks 
3 x week 
3 sets/ 10 rep 
80% 1RM 
M ( n = 7) 
74y 
W (n = 7) 
74y 
Biopsy TI 20.4 * ,TIIa 12.7 * 
 
TI 24.4 *,TIIa 6.0 
 
(n.r) 
 
(n.r) 
50.0 LB * 
 
56.0 LB * 
M = W 
Roth et al. 
2001 
24 weeks  
3 x week 
1-2 sets/ 
5RM 
M (n = 9) 
65-75y 
W (n = 10) 
65-75y 
DXA 
MRI 
B.f.  - 1.0, F.f.m. 1.0 * 
MV (thigh) 4.1 * 
B.f.  - 0.4, F.f.m. 2.1 *  
MV (thigh) 5.8 * 
- 0.7 
 
1.7 
 
14.5 WB * 
 
21.7 WB * 
M = W 
Lemmer  
et al. 2000 
9 weeks  
3 x week 
5 sets/ 5RM 
M (n = 12) 
65-75y 
W (n = 11) 
65-75y 
DXA  B.f. n.c., F.f.m 1.7 
 
B.f. - 1, F.f.m. 2.4 
1.2 
 
n.c. 
27.0 LB * 
 
29.0 LB * 
M = W 
Lemmer  
et al. 2001 
24 weeks 
 3 x week 
1-2 sets/ 
5RM 
M (n = 11) 
65-75y 
W (n = 10) 
65-75y 
DXA B.f. - 0.9, F.m. - 2.8 
F.f.m. 1.7 * 
B.f. - 0.4, F.m. 1.0 ** 
F.f.m. 2.1 * 
0.3 
 
1.7 
23.0 WB * 
 
22.8 WB * 
M = W 
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Hurlbut  
et al. 2002 
24 weeks 
 3 x week 
1-2 sets 
5RM 
M (n = 12)  
65-75y  
W (n = 9) 
65-75y 
DXA B.f. - 0.8,  F.m. - 2.5  
F.f.m. 1.5 * 
 B.f. - 0.6, F.m. n.c.  
F.f.m. 2.1 ** 
0.1 
 
1.5 
23.8 WB * 
 
22.4 WB * 
M = W 
Hunter  
et al. 2002 
25 weeks 
3 x week 
2 sets  
10RM 
M (n = 14) 
61-77y 
W (n = 12) 
61-77y 
CT, BP B.f.  - 2.7, F.m. - 9.1 * 
F.f.m. 4.7 *  
B.f. - 2.1, F.m. - 6.2 * 
F.f.m. 2.3* 
1.0 
 
- 1.0 
32.5  WB * 
 
38.5  WB * 
 M = W 
Hakkinen  
et al. 2002 
24 weeks 
2 x week 
2-4 sets 
3-12RM 
 
M (n = 10) 
60-75y 
W (n = 11) 
60-75y 
Biopsy 
S 
B.f. - 0.9 *, F.f.m. 0.9 * 
TI 50.6 *†, TIIa 48.4 *†, TIIb 46.2 
*†  
B.f. - 0.8, F.f.m. - 0.4 
TI 28.6 * , TIIa 33.2 * , TIIb 18.9 
- 0.2 
 
- 1.5 
35.0 LB * 
 
38.4 LB * 
M  > W 
 
 
Bamman  
et al. 2003 
26 weeks 
 3 x week 
2 sets 
10RM 
80% 1RM 
M (n = 9) 
61-77y 
W (n = 5) 
61-77y 
Biopsy 
BP 
B.f. - 2.9 *, F.f.m. 4.4 * 
TI 28.0 *†, TIIa 41.0*†, TIIx 42.0 
*† 
B.f. - 3.1 *, F.f.m. 4.2 * 
TI 6.5 *, TIIa 5.7 *, TIIx 5.0 * 
 
0.6 
 
- 0.8 
 
82.0 LB 
*† 
 
52.0 LB * 
M  > 
W 
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Brose et al. 
2003  
14 weeks 
3 x week 
1-3 sets 
10-12 rep  
50-80% 
1RM 
M (n = 7) 
68.3 
W (n = 7) 
69.9y 
DXA 
Biopsy 
 
B.f. - 0.2,  F.f.m. n.c. 
TI 24.2 *, TIIa 24.6, TIIx 40.6* 
B.f. - 0.9,F.f.m. 1.6 
TI 5.3 *, TIIa 3.1, TIIx 17.0* 
 
- 0.5 
 
n.c. 
36.1 WB *
 
46.0 WB *
M = W 
Ryan et al. 
2004 
24 weeks 
3 x week 
1-2 sets 
12-15RM 
M (n = 10) 
65-74y 
W (n = 10) 
65-74y 
DXA B.f - 0.8, F.m. - 2.5 
F.f.m. 1.6 * 
B.f - 0.7, F.m. - 0.6 
F.f.m. 1.7  
0.2 
 
0.7 
24.2 WB * 
 
20.8 WB * 
M = W 
 
* significantly different from baseline (P < 0.05) , ** approached significance compared to baseline (P = 0.06), † significantly different 
between groups (P < 0.05), ‡ approached significance between group (P = 0.06), DXA =  dual energy X-ray absorptiometry, CT = 
computed tomography, BP = BOD POD, CUS = compound ultrasonic scanner, MRI =  magnetic resonance image, S = skinfolds, CSA 
=  cross-sectional area, TI = type I CSA, TII = type II CSA, TIIa =  type IIa CSA, TIIb =  type IIb CSA, TIIx: =  type IIx CSA, F.m.: =  
fat mass, B.f. =  % body fat, F.f.m. = fat free mass, MV = muscle volume, LB =  lower body strength, WB = total body strength, QF = 
quadriceps femoris, H = hamstrings, BB =  biceps brachii, VL =  vastus lateralis,  n.c. =  no change, n.r. =  not reported, ♦ data taken 
from graph. 
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Introduction 
 
 Prostate cancer is the fifth most common cancer representing 19% of cancers 
among men in developed countries with more than 80% of the cases occurring in 
men older than 65 years (Parkin, Bray, Ferlay, & Pisani, 2005; Parkin, Pisani, & 
Ferlay, 1999). Traditional treatments for prostate cancer that focus on reducing the 
levels of or effects of testosterone by Androgen Deprivation Therapy (ADT) may 
lead to detrimental side effects in the musculoskeletal system (Diamond, Higano, 
Smith, Guise, & Singer, 2004; Holzbeierlein, McLaughlin, & Thrasher, 2004; 
Pickett, Bruner, Joseph, & Burggraf, 2000; Stege, 2000). Some of these side effects 
are directly related to changes in body composition with an increase in fat mass and 
reduction in muscle mass that may negatively impact physiological function 
(Holzbeierlein, McLaughlin, & Thrasher, 2004; Sharifi, Gulley, & Dahut, 2005; 
Smith, 2004; Smith et al., 2002). Moreover, these treatment side effects would 
exacerbate the age-related loss of muscle mass, termed sarcopenia, further 
compromising muscle strength, physical function and dependent living (Rosenberg, 
1997). The simultaneous increase in fat mass during ADT can lead to increased 
levels of total cholesterol and triglycerides (Sharifi, Gulley, & Dahut, 2005; Smith et 
al., 2002; Tayek et al., 1990) and consequently the possible development of 
cardiovascular complications (Holzbeierlein, McLaughlin, & Thrasher, 2004; Sharifi, 
Gulley, & Dahut, 2005). Additionally, ADT has been associated with reduced bone 
mass which can compromise bone strength and increase fracture risk (Diamond, 
Higano, Smith, Guise, & Singer, 2004; Shahinian, Kuo, Freeman, & Goodwin, 2005; 
Smith, 2002b; Smith et al., 2005) compounded by increased risk of falling 
precipitated by the reduced muscle strength.  
 Only scant information on alterations to bone mass and soft-tissue following 
ADT exist (Smith, 2004; Smith et al., 2002; Tayek et al., 1990), and there is no 
information on changes in the regional distribution of bone, lean and fat mass (i.e. 
trunk, upper, and lower limb) during therapy. Abdominal fat has been related to 
increased risk for the development of cardiovascular complication, thus, if ADT 
tends to induce greater trunk fat accumulation, alternative or adjuvant therapies 
should be devised to counteract such conditions. Similarly, are losses in muscle and 
bone mass greater at weight-bearing sites than non-weight bearing sites and can 
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strategies be incorporated into the patient’s management plan to address this?  
Moreover, these changes in body composition and tissue distribution can be directly 
related to chronic conditions that result in disability and loss of independence in 
older adults.  
  Considering that the life expectancy for prostate cancer patients has 
increased, additional information on how bone mass and body composition adapts 
during ADT seems relevant so that strategies to counter the physiological side effects 
can be devised and recommended. The purpose of the present study was to examine 
the alterations in whole body and regional bone, lean and fat mass in men that occurs 
after receiving ADT for prostate cancer.  
Methods 
Subjects 
 
 Seventy-two prostate cancer patients aged 44 to 88 years receiving 
intermittent androgen blockage had hip, spine and whole body scans by dual-energy 
x-ray absorptiometry (DXA) performed at baseline and following 36 weeks of 
treatment. The patients were a sub-group of those participating (n = 250) in a multi-
centre trial of ADT from 1999-2004, and were from the one clinical site.  Subjects 
were required to have a histological or cytological diagnosis of adenocarcinoma of 
the prostate and to have an ECOG performance status of 0, 1 or 2 at baseline. Prior 
neoadjuvant hormonal therapy did not preclude study entry provided that treatment 
had been administered more than two years ago and given for no more than six 
months. Institutional Ethics Committee approval was obtained and each participant 
provided written consent. ADT was achieved by a maximal androgen deprivation 
program employing Flutamide (Eulexin®) 250mg tid and Leuprolide (Lucrin®) 
22.5mg three monthly depot during the course of 36 weeks.  Disease extent was 
prospectively categorised as: locally advanced disease without evidence of metastatic 
disease but not considered suitable for or declining radical treatment; recurrent local 
disease following radical prostatectomy, or radical radiotherapy and associated with 
a rising PSA ≥ 2ng/mL, measured on three consecutive occasions, at intervals of at 
least one month or more apart and without evidence of metastatic disease.        
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Bone Mineral Density and Body composition  
 
 Bone mineral density (BMD, g/cm2) and content (BMC, g) of the total hip, 
spine and whole body was assessed by DXA (Hologic Discovery W, Waltham, MA). 
In addition, whole body bone mineral-free lean mass (LM) and fat mass (FM), upper 
limb lean mass and fat mass (ULLM, ULFM), lower limb lean mass and fat mass 
(LLLM, LLFM), trunk lean mass and fat mass (TrLM, TrFM) and percent body fat 
were derived from the whole body scan. Regional analysis was derived by 
manipulating segmental lines according to specific anatomic landmarks (Taaffe et 
al., 2001; Taaffe, Lewis, & Marcus, 1994). A vertical line extended between the head 
of the humerus and the glenoid fossa separated the upper limbs from the trunk, while 
an oblique line through the femoral neck separated the lower limbs from the pelvis. 
Upper limb and lower limb lean tissue mass represent the sum of left and right 
extremities. ULLM and LLLM were then combined to derive appendicular skeletal 
muscle (ASM) (Heymsfield et al., 1990; Wang et al., 1996).      
PSA, Testosterone and Blood Counts 
 
All measurements were performed on samples collect after overnight fasting. 
PSA and free testosterone was measured by chemiluminescent microparticle 
immunoassay (Architect I200SR, Abbott Diagnositics). Full blood counts were 
determined using an automated blood counting (electrical impedance, Beckman 
Coulter diagnostics). 
Bone Markers 
 
Serum osteocalcin was determined using radioimmunassay techniques as 
previously described (Kent et al., 1990). Urine calcium, urine calcium excretion and 
urine calcium / creatinine ratio were assessed using a Hitachi 917 chemistry analyser 
and alkaline phosphatase using a Hitachi modular unit.  
 
 
Height and Weight 
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 Height and weight were determined by a stadiometer and electronic scale, 
respectively, and body mass index (BMI, kg/m2) was calculated from weight divided 
by the square of height. 
 
Physical activity and Fatigue  
 
 The European Organization for Research and Treatment of Cancer EORTC 
QLQ-C30 version 2.0 core questionnaire quality of life (QOL) were used to assess 
changes in physical activity and levels of fatigue. The QLQ-C30 core questionnaire 
incorporates nine multi-item scales: five functional scales (physical, role, cognitive, 
emotional, and social); three symptom scales (fatigue, pain, and nausea and 
vomiting); and a global health and quality of life scale. Several single item symptom 
measures were also included. All scales are scored from 0 to 100. High scores for a 
functional scale represented high or healthy levels of functioning, and similarly for 
global health or quality of life. High scores for a symptom scale or item represented 
high levels of symptomatology or problem. 
 
Statistical Analyses 
 
 Data were analyzed using the SPSS (Version 11.0, SPSS Inc., Chicago, IL) 
statistical software package. Analyses included standard descriptive statistics and 
paired two-tailed Student’s t-tests. To adjust for multiple comparisons, an alpha level 
of 0.01 was set as the criterion for statistical significance. Results are given as the 
mean ± SE. 
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Results 
 
Subject characteristics are shown in Table 1. The mean age of the participants 
was 73.5 ± 1 year with a BMI of 27.1 ± 0.4 kg/m2.  Levels of serum testosterone, 
PSA and hemoglobin decreased (P < 0.001) by 93.3% ± 0.4, 98.2% ± 0.5%, and 8.8 
± 0.9, respectively and markers of bone formation and resorption increased following 
treatment (Table 2).  Additionally, following treatment, physical activity levels 
significantly decreased from 89.5 ± 2.3 to 83.5 ± 2.3 (P = 0.008) and fatigue 
increased from 16.2 ± 2.0 to 26.8 ± 2.5 (P < 0.001).  
Baseline and week 36 values as well as percent change for whole body and 
regional lean, fat and bone mass are shown in Table 3. Following treatment, whole 
body LM (1.4 ± 0.2 kg) and bone mass (61.5 ± 10.3 g) significantly (P < 0.001) 
decreased and FM increased (2.2 ± 0.3 kg). There were significant (P < 0.01) 
declines at all regional sites for LM, with the percent decline in LLLM and ULLM 
greater than that for the TrLM (P = 0.004). Conversely, fat mass increased (P < 
0.001) at all regional sites with the change in the limbs greater than the trunk (P < 
0.001). There was a significant (P < 0.001) reduction in hip and spine BMD of 1.5 % 
and 3.9 % respectively, and a decline in upper limb BMD of1.3% (P < 0.001) with 
no significant change for lower limb BMD. The decrease in bone density at the spine 
was greater than that at the hip site (P = 0.032). 
    
Discussion 
 
 The results from the present study demonstrate that 36 weeks of ADT in men 
with non-metastases prostate cancer has a deleterious effect on whole body and 
regional tissue composition by decreasing muscle and bone mass and increasing fat 
mass.  The change in soft tissue was greater for the limbs than the trunk, and for the 
older patients may contribute to a decline in their functional performance and loss of 
independence.      
 Our findings confirm the changes in whole body composition previously 
reported by Smith and associates (Smith et al., 2002) where body weight and fat 
mass increased  by 2.4% and 9.4%, respectively, and lean mass decreased by 2.7% 
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following 48 weeks of ADT. Recently, the same group(Smith, 2004) reported an 
increase of 11% in fat mass and a decrease of approximately 4% in lean mass after 
one year of ADT.  The present study extends these findings and indicates that the 
decline in lean mass from the upper and lower limbs is greater than changes 
occurring in the trunk.  This preferential loss from the limbs would be expected given 
that the trunk includes a large organ mass (which will not be affected by treatment) 
in addition to skeletal muscle. As reduced muscle mass and function are directly 
associated with impairments and compromised function in older adults (Bassey et al., 
1992; Evans, 1995), our findings would suggest that countermeasures need to be 
implemented to maintain or even reverse the rate of muscle loss in the most affected 
areas following ADT. Resistance training has been reliably shown to be a safe and 
effective strategy to improve muscle mass and function in older adults (Taaffe, 2006) 
including the very old (Fiatarone et al., 1990) and may play an important role in 
attenuating or reversing this muscle loss in ADT treated men (Galvao & Newton, 
2005).   
 We also observed an increase in fat accumulation at all regional sites with the 
upper and lower limbs showing greater changes than for the trunk. The increase in 
whole body fat is consistent with previous studies (Smith, 2004; Smith et al., 2002), 
however, we note regional differences in fat distribution with ADT.  Increased 
abdominal fat mass has been associated with a greater risk for developing coronary 
artery disease, type 2 diabetes, hyperlipidemia and premature death than accretion of 
fat mass in the extremities (ACSM, 2000). Consequently, although the accumulation 
of fat was relatively less for the trunk, strategies aimed at minimizing fat accretion 
during ADT should be explored.  In addition, the decline in lean mass would 
negatively impact basal metabolic rate and hence energy requirement and this would 
contribute to the increase in fat mass associated with ADT.  Therefore, strategies 
aimed at preserving lean mass will also assist in attenuating the increase in fat mass. 
 In the present study we also noted a significant decrease in lumbar spine and 
hip BMD and reduction of whole body BMD following therapy. A number of studies 
have reported decreases of bone mass following ADT (Diamond, Campbell, Bryant, 
& Lynch, 1998; Eriksson, Eriksson, Stege, & Carlstrom, 1995; Maillefert et al., 
1999; Shahinian, Kuo, Freeman, & Goodwin, 2005) and recent reviews(Diamond, 
Higano, Smith, Guise, & Singer, 2004; Holzbeierlein, McLaughlin, & Thrasher, 
2004) have highlighted the importance of addressing bone loss and osteoporosis in 
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this group of cancer patients. It is interesting that our analyses showed that although 
BMD decreased in the upper limbs, these changes were not observed in the lower 
limbs.  The loading that the lower extremities are subject to may have contributed to 
the preservation of bone density compared to the non-weightbearing upper 
extremities. Additionally we also noted that BMD for the spine showed greater 
reductions than at the hip. This may be attributed to the greater trabecular bone 
composition of the spine compared to the proximal femur, where earlier bone 
turnover and therefore loss of BMD in the axial skeleton may occur (Marcus, 1991).  
Maillefert and colleagues (1999) have also reported greater losses in BMD at the 
lumbar spine than femoral neck in a small group of patients following 18 months of 
ADT. We observed in addition to the changes in BMD, a marked increase in markers 
of bone resorption and formation indicating increased bone turnover.  
 In summary, we found that 36 weeks of ADT has a negative impact on whole 
body and regional tissue composition in men with non-metastatic prostate cancer. 
These changes were marked with reductions in lean mass and increases in fat mass 
occurring at all regional sites (upper limbs, lower limbs and trunk). Additionally, 
decreases in lumbar spine and hip BMD and whole body and upper limb BMD were 
observed. We propose that strategies to counteract such changes in soft tissue and 
bone mineral during ADT in older men should be implemented to minimize the risk 
of sarcopenia, osteoporosis, and obesity, and subsequent disability.  
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Table 1. Subjects Characteristics at Baseline (n = 72) 
 
 
 
 
 
 
BMI = body mass index  
 
 
 
 
 
 
 
 
 
 
 
 
 
 (Mean ± SE) Range 
Age (yr) 73.5 ± 0.9 (44.4 to 88.4) 
Height (cm) 171.2 ± 0.7 (154.5 to 186.8) 
Weight (kg) 79.6 ± 1.5 (55 to 116.3) 
BMI (kg/m²) 27.1 ± 0.4 (18 to 38) 
Body fat (%)  25.5 ± 0.6 (9 to 36) 
Table 2. Total testosterone, PSA, haemoglobin and bone markers changes following 36 weeks of Androgen Deprivation Therapy (Mean 
± SE). 
 
PSA = prostate specific antigen, * n = 63, † n = 62. 
 
 
  
 
 
 
 Baseline (n = 68) 36 weeks (n = 68) Percent change (%) P value 
Total Testosterone (pg/ml) 15.1 ± 0.6 0.80 ± 0.03 - 93.3 ± 0.3 < 0.001 
PSA (ng/ml) 22.6 ± 3.1 0.23 ± 0.05 -98.2  ± 0.5 < 0.001 
Hemoglobin (g/L) 145.2 ± 1.5 131.9 ± 1.5 -8.8 ± 0.9 < 0.001 
Bone Markers 
    Serum Osteocalcin  * 4.7 ± 0.05 7.4 ± 0.7  341.0 ± 111.2  0.002 
    Alkaline Phosphatase † 89.0 ± 6.1 99.5 ± 7.1 13.5 ± 3.0  0.001 
    Urine Calcium/Creatinine Ratio † 240.4 ± 24.6 415.3 ± 39.11 101.5 ± 12.2 < 0.001 
    Urine Calcium Excretion † 21.2 ± 2.4 35.3 ± 3.6 94.0 ± 12.0 < 0.001 
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Table 3. Body composition and bone mass changes following 36 weeks of Androgen Deprivation Therapy (Mean ± SE). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LM = bone mineral-free lean mass, ASM = appendicular skeletal muscle, TrLM = trunk lean mass, ULLM = upper limb lean mass, 
LLLM = lower limb lean mass, FM = fat mass, TrFM = trunk fat mass, ULFM = upper limb fat mass, LLFM = lower limb fat mass, 
TBBMD = total body bone mineral density, ULBMD = upper limb bone mineral density, LLBMD = lower limb bone mineral 
density, BMD = bone mineral density, * n = 69. 
 Baseline (n = 68) 36 weeks (n = 68) Percent change (%) P value 
Lean tissue mass 
   LM (kg)  55.8 ± 0.8 54.4 ± 0.8 -2.4  ± 0.4 < 0.001 
   ULLM (kg)  6.3 ± 0.1 5.9 ± 0.1 -5.6  ± 0.6 < 0.001 
   LLLM (kg)  17.1 ± 0.2 16.4 ± 0.2 -3.7  ± 0.5 < 0.001 
   TrLM (kg)  28.8 ± 0.4 28.3 ± 0.4 -1.4  ± 0.5 0.009 
   ASM (kg)  23.4 ± 0.3  22.4 ± 0.3 -4.2  ± 0.5 < 0.001 
Fat mass  
   FM (kg)  20.8 ± 0.7 23.1 ± 0.7 13.8 ± 2.3 < 0.001 
   ULFM (kg)  2.1 ± 0.1 2.5± 0.1  20.7± 3.3 < 0.001 
   LLFM (kg)  5.5 ± 0.2 6.4 ± 0.2 18.7 ± 2.7 < 0.001 
   TrFM (kg)  12.13 ± 0.4 13.1 ± 0.4 12.0 ± 2.5 < 0.001 
   Body fat (%)  25.8 ± 0.6 28.5 ± 0.7 2.6 ± 0.3 < 0.001 
Bone mass     
   TBBMD (g/cm2)  1.164 ± 0.014 1.145 ± 0.014  -2.4 ± 0.3 < 0.001 
   ULBMD (g/cm2)   1.732 ± 0.015 1.708 ± 0.015  -1.3 ± 0.3 < 0.001 
   LLBMD (g/cm2)  2.576 ± 0.038 2.559 ± 0.041   -0.6 ± 0.4 0.173 
   Total hip BMD  (g/cm2) * 1.021 ± 0.018 1.001 ± 0.018 -1.5  ± 0.5 < 0.001 
   Spine BMD (g/cm2) * 1.123 ± 0.024 1.086 ± 0.023 -3.9 ± 0.4 < 0.001 
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Introduction 
 
 
 The use of androgen deprivation therapy (ADT) in the form of gonadotropin releasing 
hormone (GnRH) agonists for prostate carcinoma increased extensively across all stages and 
histologic grades of prostate cancer in the past decade (Cooperberg, Moul, & Carroll, 2005; 
Shahinian, Kuo, Freeman, Orihuela, & Goodwin, 2005). However, the reduction in 
testosterone levels by ADT is accompanied by a number of adverse side effects (Basaria et al., 
2002; Basaria, Muller, Carducci, Egan, & Dobs, 2006; Diamond, Higano, Smith, Guise, & 
Singer, 2004; Shahinian, Kuo, Freeman, & Goodwin, 2005; Sharifi, Gulley, & Dahut, 2005; 
Smith et al., 2001). Some of these side effects include reduction of muscle strength, lean and 
bone mass, increased fat mass and risk of fracture, unfavorable lipid profile and depression 
compromising physical and  physiological function (Greenspan et al., 2005; Shahinian, Kuo, 
Freeman, & Goodwin, 2005; Sharifi, Gulley, & Dahut, 2005; Smith, 2004; Stoch et al., 2001). 
Importantly, these side effects are closely related to an increased risk of developing other 
chronic conditions (Basaria, Muller, Carducci, Egan, & Dobs, 2006; Shahinian, Kuo, 
Freeman, & Goodwin, 2005; Sharifi, Gulley, & Dahut, 2005). Increases of ~7-10% in fat 
mass and decreases of ~ 2-4% in lean mass after one year of ADT have been reported in 
recent studies (Greenspan et al., 2005; Lee, McGovern, Finkelstein, & Smith, 2005; Smith, 
2004; Smith et al., 2002) as well as reduced muscle strength (Basaria et al., 2002). 
Additionally, substantial decreases in trabecular and cortical bone mass have been found 
following administration of ADT with a concomitant increased risk for fracture at multiple 
skeletal sites (Shahinian, Kuo, Freeman, & Goodwin, 2005; Smith et al., 2005). As a result, 
strategies to preserve body composition and improve physical function may reduce falls risk, 
fracture, and subsequent complications. 
  Existing treatments to alleviate these side effects have been predominantly 
pharmaceutical, however, these treatments are expensive, and their effects do not translate 
into improved physical and functional capacity. To date, most of the experimental studies 
examining the role of exercise during cancer treatments have included breast cancer patients 
and aerobic exercise rather than resistance exercise (Courneya, 2003; Galvao & Newton, 
2005). In view of the extensive scientific literature supporting resistance training as the most 
effective exercise mode for improving muscle strength, physical function and counteracting 
sarcopenia in older adults (Fiatarone et al., 1990; Frontera, Meredith, O'Reilly, Knuttgen, & 
Evans, 1988a; Taaffe, 2006), resistance exercise may have a significant role in preventing the 
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catabolic effects of ADT by promoting a sufficient anabolic environment which can lead to 
positive musculoskeletal benefits and enhanced physical function.  
 Segal and associates (2003) recently reported positive changes in quality of life and 
fatigue outcomes subsequent to a short-term resistance training program in prostate cancer 
patients undertaking testosterone suppression. However, questions remain regarding the 
adaptive response of specific physiological and physical parameters, such as body 
composition, muscle hypertrophy, bone mineral density, functional performance and balance 
in a longer-term trial in this population. We therefore designed a non-randomized clinical trial 
to examine the possible effects of a 20-week high intensity progressive resistance training 
program on muscle function, functional performance, balance, body composition and muscle 
thickness in older men receiving ADT for prostate cancer. 
 
Methods  
 
 Ninety-one prostate cancer patients, referred by oncologists and urologists or who 
responded to advertisements via local newspaper and radio in the city of Perth, Western 
Australia from February through July 2005, were initially screened for participation in the 
study (Figure 1). Exclusion criteria included: no histologically documented prostate cancer, 
not receiving ADT in the previous 2 months, not scheduled to receive ADT for the subsequent 
6 months, metastatic disease, any musculoskeletal, cardiovascular, or neurological disorder 
that could inhibit them from exercising, inability to walk 400 m or undertake upper and lower 
limb exercise, resistance training in the previous 12 months, and unwillingness to undertake 
20 weeks of resistance training. Eleven men were eligible and invited for familiarization 
sessions. One subject withdrew from the study at week seven because of an acute respiratory 
infection that resulted in several weeks of hospitalization (Figure 1). Prior to participation, all 
subjects obtained medical clearance from their physician and completed a health history 
questionnaire. Regarding the activity levels of the subjects prior entering the intervention, 
seven men were not undertaking any form of structured exercise, one was a regular walker, 
one a regular walker and jogger, and lastly, one was a recreational bowling player. The study 
was approved by the university Human Research Ethics Committee and all subjects provided 
written informed consent.  
 
                                                      Resistance Training in Men Receiving ADT     
 
 67
Training Program  
 
 Ten subjects undertook 20 weeks of high-intensity progressive resistance training 
twice a week for 20 weeks. The initial 10 weeks provided an introductory resistance exercise 
phase consisting of hydraulic resistance training machines (Isotronic, Fitness Technology, 
Australia) that are simple and time efficient to use, and provide exclusively concentric muscle 
contractions likely to facilitate training initiation in this clinical group of men. The exercises 
included the chest press, seated row, shoulder press, lat pull down, triceps extension, biceps 
curl, leg press, squat, leg extension, leg curl, abdominal crunch and back extension exercises. 
In the following 10 weeks, the training program was altered to isotonic resistance which 
provides concentric and eccentric muscle contractions using similar exercises on different 
apparatus (Cybex, Strength Equipment, USA). During this period, the lat pull down and 
shoulder press exercises were alternated with the biceps curl and triceps extension exercises 
every other session to maintain an exercise session length of 1 hour. In every session, general 
flexibility exercises as well as one set for the first upper and lower body exercise at a lower 
training intensity were undertaken to ensure adequate warm-up before the training program. 
Both training phases were designed to progress from 12 to 6-repetition maximum (RM) for 2 
to 4 sets per exercise. Briefly, both training phases were designed as weeks 1-2 (2 sets of 12-
RM), weeks 3-4 (3 sets of 10-RM), weeks 5-7 (3 sets of 8-RM) and weeks 8-10 (4 sets of 6-
RM) and were based on the American College of Sports Medicine position stand on 
progression models in resistance training for healthy adults (Kraemer et al., 2002).  All 
sessions were conducted in small groups of 1-4 participants under direct supervision to ensure 
safety, proper intensity and appropriate exercise technique. Additionally, all participants 
recorded their training weights, number of repetitions and sets performed in an individual 
exercise log to ensure adequate progression.  
 
Muscle Function 
 
Measures of muscle function included dynamic isotonic muscle strength and 
endurance and were assessed at baseline, week 10 and week 20. 
Dynamic Isotonic Muscle Strength 
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 Participants underwent two familiarization sessions that included instruction regarding 
correct exercise technique and practice performing 2 sets of 12 repetitions on all hydraulic 
resistance machines in addition to the chest press, seated row and leg press isotonic resistance 
machines before muscle strength was determined. Dynamic isotonic muscle strength for the 
chest press, seated row and leg press were measured using 1-RM, as described previously 
(Taaffe, Duret, Wheeler, & Marcus, 1999). The 1-RM is the maximal weight an individual 
can move through a full range of motion by maintaining proper exercise technique and not 
changing body position other than that of the specific exercise motion.  
The coefficient of variation in our laboratory for repeated 1-RM measures performed 
approximately 1 week apart is 2.2% to 7.5%.  
Dynamic Isotonic Muscle Endurance 
Muscle endurance was measured using the maximal number of repetitions performed 
at 70% of 1-RM for the chest press and leg press exercises (Galvao & Taaffe, 2005). For 
week 10 and week 20 assessments, the baseline and either the week 10 or final 1-RM value, 
respectively, was used to determine the resistance. The coefficients of variation performed 
approximately 1 week apart for the chest press and leg press muscle endurance are 6.3% and 
6.8%, respectively.        
 
Physical Performance   
 
 A battery of tests was used to assess functional performance at baseline, week 10 and 
week 20. Tests were performed in triplicate (except for the 400-m walk) with sufficient 
recovery time between trials (Galvao & Taaffe, 2005). The fastest time recorded was used in 
the analyses 
 
Chair Rise to Standing 
 
 Subjects were seated in a hard-backed chair, with a seat height of 43 cm from the 
floor, with their arms folded across their chest. They were instructed to rise as fast as possible 
to a full standing position then return to a full sitting position 5 times(Galvao & Taaffe, 2005; 
Taaffe, Duret, Wheeler, & Marcus, 1999). The coefficient of variation in our laboratory for 
the repeated chair rise is 5.6%.  
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6-Meter Walk 
 
 Two measures of gait speed were undertaken: usual pace, in which subjects were 
instructed to walk at a pace similar to which they may use during common daily events; and a 
fast pace (Fiatarone et al., 1990). Time taken was determined using 2 timing gates (Swift 
Performance Equipment, NSW, Australia). The coefficients of variation in our laboratory for 
usual and fast walk are 5.6% and 6.7%, respectively.  
6-Meter Backwards Walk 
 
 As a measure of dynamic balance, subjects walked backwards 6 meters placing one 
foot directly behind the heel of the other with the shoes touching (Fiatarone et al., 1990; 
Taaffe, Duret, Wheeler, & Marcus, 1999). Time taken was assessed using timing gates. 
Subjects were spotted by an investigator and if they deviated from the line (lost their balance), 
they were instructed to move back to the line and continue the test, which increased the time 
required. The coefficient of variation in our laboratory for the backward walk is 9.4%.  
Stair Climb 
 
Subjects were instructed to climb a flight of stairs (13 stairs per flight, 17 cm rise per 
stair) as rapidly as they could safely manage without use of the handrails (Galvao & Taaffe, 
2005). Two subjects required use of the handrails to perform this test. The coefficient of 
variation in our laboratory for the stair climbing is 4.8%.  
400-Meter Walk 
 
 For the test of walking endurance, participants were required to walk 400 meters, 
which consisted of 10 laps out and back over a 20-meter course, as fast as they could at a pace 
they could maintain over the distance (Galvao & Taaffe, 2005; Taaffe et al., 2003). The 
coefficient of variation in our laboratory for the 400 meters walk is 2.5%.  
Sensory Organization Test  
 
 The sensory organization test (SOT) was measured using the Neurocom Smart 
Balance Master (Neurocom International Inc., USA). SOT consists of averaging three 
equilibrium scores for six trial conditions. Subjects stood on the Neurocom force plate 
without socks or any footwear and with a security belt attached (in case of a fall). According 
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to the manufacturer’s protocol and previous studies (Wallmann, 2001) subjects undertook 
three 20-second trials for each of the following conditions: 1) Eyes open, fixed support 
surface and surround (visual, vestibular, and somatosensory input); 2) Eyes closed, fixed 
support surface and surround (absent of visual input); 3) Eyes open, fixed support surface and 
sway-referenced surround (visual input imprecise); 4) Eyes open, fixed surround and sway 
referenced support surface (somatosensory inputs imprecise); 5) Eyes closed, fixed surround 
and sway referenced support surface (somatosensory inputs imprecise and absent of visual 
input); and 6) Eyes open, sway-referenced support surface and surround (imprecise 
somatosensory and visual inputs). The Equilibrium score was reported as a value between 0 
and 100, with 0 indicating a large sway and loss of balance, and 100 indicating perfect 
stability. The coefficient of variation for the SOT is 1.5%.  
 
Body Composition and Bone Mineral Density 
 
 Bone mineral density (BMD, g/cm2) of the hip (femoral neck, trochanter and Ward’s 
triangle) and total body bone mineral content (BMC, g) was assessed by dual energy X-ray 
absorptiometry (DXA, Norland XR-36, Wisconsin, USA). In addition, bone mineral-free lean 
mass (LM), fat mass (FM), and percent fat were derived from the whole body scan. The 
whole body scan was performed at baseline, week 10 and week 20, while the hip scan was 
performed at baseline and week 20. Coefficients of variation in our laboratory (duplicate 
scans with repositioning) for body composition components are less than 1.0%.  
 
 
Muscle Thickness 
 
 Muscle thickness was assessed using B-mode ultrasound (Aloka, SSD-500, Tokyo, 
Japan) at four anatomical sites [anterior (biceps brachii) and posterior (triceps brachii) upper 
arm at 60% distal between the lateral epicondyle of the humerus and the acromial process of 
the scapula; anterior (vastus lateralis and rectus femoris) and posterior (biceps femoris) thigh 
at 70% thigh length between the greater trochanter and lateral condyle of the femur] similar to 
the methods described previously by Abe et al (Abe, DeHoyos, Pollock, & Garzarella, 2000). 
A 5-MHz scanning probe coated with a water soluble gel was placed on the skin 
                                                      Resistance Training in Men Receiving ADT     
 
 71
perpendicular to the tissue interface. The subject was seated during the upper limb 
measurement with the elbow extended and relaxed and in a standing position during the lower 
limb measurement with the knee extended and relaxed. The muscle thickness measurement 
was extracted from the ultrasonic image, with the distance between the subcutaneous adipose 
tissue muscle-interface to the muscle-bone interface taken as muscle thickness (Abe, 
DeHoyos, Pollock, & Garzarella, 2000). Two muscle thickness measurements were obtained 
at each of the four sites and averaged to attain the final value. Great care was taken marking 
the skin via anthropometric techniques, and printed images of baseline measures were 
available during the week 10 and 20 repeated measurements to ensure identical sites were 
assessed.  
The coefficient of variation for muscle thickness using repeated ultrasound images in our 
laboratory is less than 3.5%.   
 
Blood Sampling 
              Venous blood samples were drawn from a forearm vein at a fixed time (8:30 AM -
10:00 AM) at baseline, week 10, and week 20 into sterile vacutainers containing K2-EDTA 
and serum separation tubes (Becton Dickinson, 
Franklin Lakes, NJ, USA). The blood corrected by K2-EDTA tube was used for the 
measurement of hemoglobin concentration by an automatic full blood counts analyser 
(Sysmex XE-AlphaN, Sysmex Corporation, Kobe, Japan).  The serum separation tubes was 
left at room temperature for the blood to clot, and centrifuged for 10 min at 3000 rpm at 4oC. 
The serum samples were stored in 0.7mL aliquots at –80oC until the day of analysis for 
prostate specific antigen (PSA), free testosterone, growth hormone, and cortisol 
concentrations.   
 
Analysis of PSA, Serum Hormones and Hemolobin  
 
             PSA was measured by an Immurise analyser (Beckman Coulter Inc., Fullerton, CA. 
USA) using a test kit (Diagnostic Products Corporation, Los Angeles, CA, USA).   Serum 
concentrations of the hormones were determined by RIA using a test kit (free testosterone: 
DPC free testosterone kit, Diagnostic Products Corporation, Los Angeles, CA, USA; growth 
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hormone: GH Kit, SRL Co., Tokyo, Japan; cortisol: Cortisol Kit, Immunotech, Beckman 
Coulter Inc., Praque, Czeck Republic). 
 
Statistical Analyses 
 
 Data were analysed using the SPSS (Version 11.0, SPSS Inc, Chicago, IL) statistical 
software package and included standard descriptive statistics, analysis of variance (ANOVA) 
and covariance (ANCOVA). Repeated measures ANOVA was used to compare subjects over 
the three time-points, and ANCOVA was used to compare responses at week 20, adjusted for 
the baseline value, between acute (< 12 months) and chronic (> 12 months) users of ADT. 
Where appropriate, the Fisher Protected LSD test was employed to locate the source of 
significant differences.  An alpha level of 0.05 was required for significance and results are 
given as the mean ± SD. The statistical power to detect change in the primary study outcomes 
(physical and functional performance) over the 20-week intervention ranged from 0.75 to 1.0. 
 
Results 
 
 Subject characteristics are shown in Table 1. All men were receiving ADT before 
entry to the study with a mean duration of 1135 ± 1360 days. Six men were on GnRH 
agonists, four men were on maximal blockage therapy (GnRH agonists + antiandrogens), and 
one was on antiandrogens. Five men were on acute (initiating ADT within the last 12 months, 
mean 156 ± 97days) and the remaining six were on chronic (receiving ADT for 12 months or 
longer, mean 1951 ± 1391 days ) ADT. All subjects were treated with ADT during the entire 
course of the study (including pre-, mid- and post-test measures and for all 40 training 
sessions) over a 6-month period.   
 
Dynamic Muscle Strength and Muscle Endurance 
 
 Baseline, week 10, week 20 and percentage change in muscle strength and endurance 
values are reported in Table 2. There was a significant increase in strength for all three 
exercises with a continuous improvement for both upper and lower body strength from 
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baseline to week 10 and week 20 (p<0.001). Similarly, upper and lower body muscle 
endurance (number of repetitions performed) increased (p<0.001) when 70% of the1-RM 
baseline load was used during retesting. Muscle endurance assessed using 70% of the1-RM 
post-test load also increased (p =0.024) for the leg press exercise and approached significance 
(p=0.085) for the chest press. 
 
Physical Performance and Sensory Organization Test 
 
 After the 20-week training period, there was a significant improvement (p<0.05) in the 
chair rise, 6-m usual walk speed, backward walk speed, 400-m corridor walk, and stair 
climbing test (Table 3). Additionally, the change in the chair rise, stair climbing, 6-m usual 
walk and 400-m walk time was significantly different between baseline and week 10. There 
was also a significant increase in the SOT equilibrium score (p=0.042).  
 
Body Composition and Bone Mineral Density 
 
 There was no change for LM, FM, percent body fat, whole body BMC, or hip BMD 
(Table 4), however, quadriceps muscle thickness increased by 15.7 ± 12.1 % (p=0.050). There 
were no significant differences between acute (< 12 months) and chronic users of ADT for the 
outcome variables (data not shown). 
 
Serum Hormones and PSA  
 
 After the 10- and 20-week training period, there were no changes for free testosterone, 
total testosterone, GH, cortisol and PSA (Table 5). It should be noted that one subject (Table 
1) initiated the study with a relatively high PSA level and experienced a subsequent drop in 
this marker during the intervention. Excluding this subject from the analyses resulted in PSA 
values of 0.94 ± 1.4 ng/ml, 0.92 ± 1.2 ng/ml, and 0.86 ± 1.2 ng/ml (p = 0.945) at baseline, 
week 10, and week 20, respectively.   
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Discussion 
 
 This is the first study to comprehensively examine the effects of high intensity 
progressive resistance training on muscle function, functional performance, balance, body 
composition and muscle thickness in men receiving ADT for prostate cancer. Substantial 
improvements in muscle strength and endurance, as well as muscle thickness resulted while 
body composition and bone mass were preserved during the 20-week intervention. 
Importantly, these changes were accompanied by enhancement in several measures of 
functional performance and balance. These results suggest that high intensity resistance 
exercise can be safely tolerated in this group of men receiving ADT and enhanced muscle and 
physical function ensues despite a compromised hormonal profile. These findings extend 
those reported by Segal et al.(Segal et al., 2003) who found an increased quality of life and 
decreased fatigue in men on ADT following 12 weeks resistance training, and provides a 
rationale for why these benefits were observed.   
 In the present study, we found significant increases in muscle strength of 40 to 96%, 
which are comparable to the effects of this exercise mode in healthy older adults not on ADT 
(Galvao, Newton, & Taaffe, 2005). These observed changes are likely to be mediated by 
nonhypertrophy –related factors such as neural adaptations to resistance training as previously 
described (Sale, 1988). We also assessed the effects of training on muscle endurance, an 
important neuromuscular parameter that has received only modest attention in exercise studies 
(Galvao & Taaffe, 2005), and observed considerable improvement for both the upper and 
lower body, especially when the baseline load was used during retesting. Similar 
enhancement of muscle endurance using a comparable exercise intervention in community-
dwelling healthy older adults not on ADT has been previously reported (Galvao & Taaffe, 
2005) and indicates that older adults, including those on ADT, may accomplish daily tasks 
more easily and with less fatigue following training . The combined results of increased 
muscle strength and endurance in the present study could partially explain the reduced levels 
of fatigue observed in the study by Segal et al. (Segal et al., 2003). 
 Changes in several functional performance measures were also observed in our cohort 
of men, and these changes are comparable to previous studies in healthy older adults 
undertaking resistance training (Galvao & Taaffe, 2005; Taaffe, Duret, Wheeler, & Marcus, 
1999). Our results are particularly important as it implies a greater reserve capacity, and also 
that daily activities can be more easily performed by using a lower percentage of maximal 
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strength and endurance, thereby promoting enhanced independence. In addition, balance was 
improved following training. The SOT equilibrium score has previously been used to discern 
fallers from non-fallers in healthy older adults (Wallmann, 2001). Skeletal fracture risk is now 
recognized as a major side effect from GnRH agonist treatment (Shahinian, Kuo, Freeman, & 
Goodwin, 2005; Smith et al., 2005) and a relationship between the number of GnRH doses 
received during the initial twelve months after diagnosis and subsequent risk for fracture has 
been reported (Shahinian, Kuo, Freeman, & Goodwin, 2005). Our findings of improved 
functional performance and balance following an exercise program could markedly contribute 
to a reduction in falls and hence a reduced fracture risk during GnRH administration. 
 A large reduction in lean and bone mass and an increase in body fat are well 
established side effects from ADT (Diamond, Higano, Smith, Guise, & Singer, 2004; 
Greenspan et al., 2005; Lee, McGovern, Finkelstein, & Smith, 2005; Shahinian, Kuo, 
Freeman, & Goodwin, 2005; Sharifi, Gulley, & Dahut, 2005; Smith et al., 2005). Importantly, 
it has been suggested that these negative changes in soft tissue are more severe in the first 
twelve months of ADT (Greenspan et al., 2005). In the present study, whole body lean mass, 
fat mass and BMC, in addition to hip BMD, were preserved irrespective of acute or chronic 
ADT exposure. This is an important outcome as these well known detrimental changes in the 
muscular and skeletal system are closely related to other chronic conditions (Shahinian, Kuo, 
Freeman, & Goodwin, 2005; Sharifi, Gulley, & Dahut, 2005; Smith et al., 2005) that can 
compromise independence, possibly affecting mortality. In addition to whole body soft tissue, 
we also examined local changes in skeletal muscle (targeted by the exercises) assessed by 
ultrasound. Interestingly, quadriceps thickness increased by 15% despite a severely reduced 
anabolic hormone environment. 
 Serum testosterone and PSA did not change during the study indicating that this 
exercise mode can safely be undertaken in prostate cancer patients on ADT without 
compromising the therapy purpose of reduced androgen levels. The lack of change in 
testosterone and PSA is consistent with the only other published study in the area of resistance 
exercise and prostate cancer (Segal et al., 2003). Further, GH, which could mediate resistance 
training induced adaptations, did not change as a result of the intervention. Additionally, we 
found that hemoglobin was also unaltered in our cohort which may also provide a basis for 
Segal et al. (Segal et al., 2003) findings on reduced levels of fatigue following training. 
Anaemia has been reported as one ADT-related side effect with reductions in hemoglobin 
ranging from ~7-30% following therapy (Smith, 2004; Smith et al., 2002; Strum, McDermed, 
Scholz, Johnson, & Tisman, 1997). The maintenance of hemoglobin levels in our group of 
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men following 20 weeks of exercise, as well as the enhancement in muscle strength and 
endurance, provides a likely mechanism for the prevention of fatigue in resistance trained 
men on ADT.  
 Several limitations of the trial are worthy of comment. Although all subjects were 
undertaking ADT during the course of the study, duration of use varied. However, we found 
similar responses in training adaptations irrespective of acute or chronic ADT exposure, 
possibly due to the low number of subjects in the sub-analysis. In addition, a randomized 
controlled trial would have been a stronger experimental design. However, it is likely that a 
control group after six months on ADT would have decreased in the study parameters and, as 
such, differences in the exercise group would appear even more substantial. It is important to 
point out that during the recruitment phase, all men reported that they would not have 
complied with a 20-week control period if allocated to a control group suggesting that future 
exercise trials should attempt to use alternative control exercise groups (e.g. cardiovascular, 
flexibility training) as a strategy to enhance long-term exercise study designs. Nevertheless, 
our study employed a comprehensive battery of measures to assess muscle and physical 
function, as well as balance, and DXA and compound ultrasound to study change in soft 
tissue. Lastly, our subjects were well-functioning individuals mostly motivated to undertake 
the training program and may not be representative of all older men undertaking ADT for 
prostate cancer.  
 In summary, the present study indicates that resistance exercise has beneficial effects 
on muscle strength, functional performance and balance in older men receiving ADT for 
prostate cancer and should be considered for preserving body composition and reducing 
musculoskeletal side effects. Randomized controlled trials are warranted to confirm these 
findings, and future studies are possible including multi-site. Further, behavioural oncology 
groups committed to conducting behavioural interventions to assist the recruitment of larger 
study groups would be desirable. Finally, longer exercise periods (>5 months) and training 
during intermittent regimens of ADT are yet to be examined. 
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Figure1. Recruitment and Flow of Participants Through the Exercise Study 
  
Excluded (n=29) 
Off ADT before 5 months (n=16) 
Not interested (n=6) 
Unable to train for 20 weeks (n=3) 
GP not approved participation (n=2) 
Too Busy (n=2) 
Excluded (n=49) 
Not on ADT (n=21) 
Off ADT within next 5 months (n=14) 
Metastatic disease (n=5) 
GP not approved participation (n=3) 
Current undertaking resistance t. (n=3) 
Too Busy (n=2) 
No histological documented pc (n=1) 
 
  
55 prostate cancer survivors 
responded to local radio and 
newspaper advertisements
36 prostate cancer survivors 
were referred by oncologist 
and urologist 
Eligible for 
participation 
(n=6)
Eligible for 
participation 
(n=7)
Undertook baseline 
measures (n=11) 
Excluded due to 
neurological 
disorder (n=1) 
Dropped out due 
to a minor stroke 
(n=1)
Completed 20 weeks of training (n=10) 
91 subjects were contacted
Dropped out due to a severe 
respiratory infection (n=1) 
Table 1. Subjects Baseline Characteristic 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Subject Age  (years) 
Diagnosis 
(days) 
 ADT 
(days) 
Free 
Testosterone 
(pg/ml) 
PSA 
(ng/ml) 
Weight 
(kg) 
BMI 
(kg/m2) Type of ADT 
1 79 336 65* 0.79 20.30 66.9 24.3 LHRHa+A 
2 65 92 88* 0.26 0.83 73.0 26.8 LHRHa 
3 72 184 120* 7.99 1.20 96.7 31.9 LHRHa 
4 66 363 210* 0.35 0.04 97.3 32.1 LHRHa 
5 59 365 300* 0.15 0.03 68.1 21.2 LHRHa+A 
6 72 732 420† 0.87 0.05 75.8 26.2 LHRHa 
7 62 2520 720† 9.96 0.04 88.6 29.9 A 
8 82 1821 1622† 0.65 2.70 69.9 24.2 LHRHa 
9 63 3605 3240† 0.37 3.60 85.6 28.5 LHRHa+A 
10 73 3960 3955† 0.35 11.80 76.8 28.0 LHRHa+A 
         
Min 59  92 65 0.15 0.04 66.9  21.2  - 
Max 82 3960 3955 9.96 20.30 97.3 32.1 - 
Mean 70.3 1397.8 1135.6 2.13 3.09 80.2 27.4 - 
SD 8.3 1481.8 1360.4 3.64 6.58 10.9 3.3 - 
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BMI = body mass index, LHRHa = luteinizing hormone-realizing hormone agonist,  
A = antiandrogen, * = acute ADT, † = chronic ADT 
 
Table 2. Muscle Strength and Endurance at Baseline and Following 10 and 20 Weeks Resistance Training (Mean ± SD). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Significant difference, P < 0.05, abaseline to week 10, bbaseline to week 20, cweek 10 to week 20. 
1-RM = one repetition maximal, end. = muscle endurance at baseline test 70% of 1-RM, end. † = muscle endurance at post test 70% of 1-
RM, rep = number of repetitions performed.  
 
 
 
Variable Baseline Week 10 Week 20 
Percentage 
change 
P value 
Chest press 1-RM (kg) 30.9 ± 13.2 39.5 ± 15.4a 43.0 ± 16.4b,c 40.5 ± 18.5 <0.001 
Seated Row 1-RM (kg) 36.4 ± 7.3 44.6 ± 7.3a  50.7 ± 7.6b,c 41.9 ± 21.4 <0.001 
Leg press 1-RM (kg) 81.3 ± 34.2 109.0 ± 37.0a  158.0 ± 63.1b,c 96.3 ± 25.7 <0.001 
Chest press end. (rep)  9.0 ± 2.5 13.8 ± 2.2a 20.2 ± 5.5b,c 114.9 ± 42.6 <0.001 
Chest press end.†(rep) 9.0 ± 2.5 7.3 ± 2.2 9.4 ± 2.0  3.2 ± 31.7 0.085 
Leg press end. (rep) 20.3 ± 7.9 35.8 ± 10.8a 47.2 ± 10.5b 167.1 ± 143.6 <0.001 
Leg press end.†(rep) 20.3 ± 7.9 25.0 ± 8.4 27.2  ± 8.6b 56.3 ± 94.5 0.024 
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Table 3. Functional Performance Measures and Sensory Organization Test (SOT) at Baseline and Following 10 and 20 Weeks Resistance 
Training (Mean ± SD). 
 
Significant difference, P < 0.05, abaseline to week 10, bbaseline to week 20, cweek 10 to week 20. 
Variable Baseline Week 10 Week 20 
Percentage 
change 
P value  
Chair rise (s) 15.4 ± 4.9 11.3 ± 3.5a 10.5 ± 2.7b -26.8 ± 7.1 <0.001 
6-m backwards walk (s) 23.5 ± 9.3 18.7 ± 10.1 17.7 ± 10.1b -22.3 ± 21.9 0.017 
6-m usual walk (s) 5.0 ± 1.0 4.5 ± 0.8a 4.3 ± 0.7b -14.1 ± 10.2 0.002 
6-m fast walk (s) 3.7 ± 0.7 3.5 ± 0.7 3.5 ± 0.7 -5.5 ± 10.4 0.227 
400-m walk (s) 283.1 ± 60.0 255.6 ± 40.8a 252.1 ± 46.5b,c       -7.4 ± 5.9 0.003 
Stair climb (s) 7.0 ± 3.6 6.5 ± 3.9a 6.3 ± 2.9b -10.4 ± 9.8 0.014 
SOT (0-100) 68.7 ± 8.3 72.7 ± 6.1 75.7 ± 6.9b 7.8 ± 6.9 0.042 
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Table 4. Body Composition, Whole Body Bone Mass, Hip BMD and Muscle Thickness at Baseline and Following 10 and 20 Weeks 
Resistance Training (Mean ± SD). 
 
b Baseline to week 20, P < 0.05. 
Variable Baseline Week 10 Week 20 
Percentage 
change 
p value  
Bone mineral-free lean mass (kg) 52.2 ± 5.6 52.2 ± 5.8 52.0 ± 5.7 -0.4 ± 2.2 0.844 
Fat mass (kg) 25.7 ± 8.5  25.0 ± 8.5  24.9  ± 8.4 -0.0 ± 6.1 0.823 
Percentage body fat 30.7 ± 7.2 30.5 ± 6.7 30.6 ± 6.7 0.3 ± 5.3 0.852 
Total BMC (g) 3055.5 ± 396.4 3073.1 ± 430.7 3063.2 ± 410.2 0.2 ± 2.5 0.763 
Fem neck BMD (g/cm2) 0.868 ± 0.123  - 0.880 ± 0.115 1.6 ± 5.3 0.422 
Trochanter BMD (g/cm2) 0.817 ± 0.110  - 0.820 ± 0.124 0.3 ± 4.7 0.806 
Wards triangle BMD (g/cm2) 0.590 ± 0.124  - 0.596 ± 0.145 0.8 ± 7.0 0.751 
Biceps thickness (cm) 2.69 ± 0.54 2.83 ± 0.43 2.91 ± 0.57 3.5 ± 6.9 0.621 
Triceps thickness (cm) 1.94 ± 0.26 2.22 ± 0.51 2.33 ± 0.49 5.5 ± 17.0 0.875 
Quadriceps thickness (cm) 2.15 ± 0.30 2.24 ± 0.42 2.46 ± 0.41b 15.7 ± 12.1 0.050 
Hamstrings thickness (cm) 4.52 ± 0.74 4.31 ± 0.99 4.53 ± 0.89 0.2 ± 10.0 0.483 
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Table 5. Prostate Specific Antigen (PSA), Testosterone, Growth Hormone (GH), Cortisol, and Hemoglobin Following 10 and 20 Weeks of 
Resistance Training (Mean ± SD). 
 
 
* ANOVA (baseline, week 10 and 20) 
 
 
 
 
 
 
 Baseline Week 10  Week 20 * p value 
PSA (ng/ml) 3.09 ± 6.58 1.28 ± 1.58 0.90 ± 1.13 0.374 
Free Testosterone (pg/ml) 2.13 ± 3.64 2.15 ± 3.61 1.56 ± 3.68 0.532 
GH (ng/ml) 0.72 ± 0.75 0.83 ± 0.78 0.48 ± 0.37 0.239 
Cortisol (ng/ml) 10.63 ± 3.54 10.35 ± 3.32 10.42 ± 2.67 0.979 
Hemoglobin (g/L) 141.3 ± 13.1 142.3 ± 14.4 141.2 ± 13.5 0.913 
Chapter 6 
 
 
CONCLUSIONS AND IMPLICATIONS 
FOR FUTURE RESEARCH 
 
 
 This chapter summarizes the findings from the literature reviews and 
experimental studies presented in the previous chapters and highlights future areas of 
research that are warranted in the field of exercise and prostate cancer. 
  In literature review 1 (chapter 2), 26 published studies undertaken during and 
after cancer therapy are summarized. The review provides an outline of exercise 
studies and benefits derived during and after cancer therapy and is presented by 
specific exercise modes as cardiovascular, resistance and flexibility training. The 
majority of studies examined the effect of cardiovascular exercise, and breast cancer 
was the most common cancer type examined. Only scant information on exercise 
during prostate cancer therapy exists as just one trial examined the effect of 
resistance training on rates of fatigue, health-related quality of life and muscle 
strength in prostate cancer patients undertaking ADT. Although more research is 
required in this important area we have provided some guidelines and possible 
physiological outcomes from specific exercise modes. Consequently, future studies 
should examine the beneficial role that exercise may have in various cancer patient 
populations, and during various treatments and stages of the disease.    
  In literature review 2 (chapter 3) resistance exercise induced anabolic 
adaptations in older men and women were examined by summarizing 16 studies. 
Comprehensive information regarding resistance training as an exercise modality in 
an aging non-cancer population is provided with a range of different assessment 
techniques used among studies examining anabolic adaptations following training. It 
is clear that resistance training is the most effective exercise mode to reduce the age-
related loss of muscle mass and strength and the capacity to adapt with age is 
preserved. Emphasis on the effects of these adaptations between older men and 
women responses is discussed. As such, the majority of studies directly examining 
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anabolic responses to resistance training in older men and women support 
comparable responses following 9 to 42 weeks of exercise with similar relative 
increases in muscle strength. A number of specific assessment techniques undertaken 
in studies with healthy older adults were in our experimental studies (e.g. DXA, 
Ultrasound, 1-RM). 
 In experiment 1 (chapter 4) we investigated the effects of 36 weeks of 
maximal androgen blockage in 72 prostate cancer patients on regional body 
composition changes, bone mass, hemoglobin and bone markers. Seventy-two 
prostate cancer patients receiving intermittent androgen blockage undertook hip, 
spine and whole body scans by DXA performed at baseline and following 36 weeks 
of treatment. We found that 36 weeks of ADT has a negative impact on whole body 
and regional tissue composition in men with localized prostate cancer. These changes 
were marked with reductions in lean mass and increases in fat mass occurring at all 
regional sites (upper limbs, lower limbs and trunk). Additionally, decreases in 
lumbar spine and hip BMD and whole body and upper limb BMD were observed. 
Further, we observed in addition to the changes in BMD, a marked increase in 
markers of bone resorption and formation indicating increased bone turnover. As 
such, we suggested that strategies to counteract such changes in soft tissue and bone 
mineral during ADT in older men are essential to minimize the risk of sarcopenia, 
osteoporosis, and obesity, and subsequent disability. These findings in addition to 
other recent studies in the area (Greenspan et al., 2005; Sharifi, Gulley, & Dahut, 
2005) creates an important rationale to experiment 2 where the effects of a  20-week 
progressive resistance exercise program in men on established ADT for prostate 
cancer is examined.  
 In experimental study 2 (chapter 5), the effects of a progressive 20-week 
resistance program on the physical, physiological and morphological responses in 
prostate cancer patients receiving ADT was investigated. As reviewed in Chapter 
two (review of literature 1) to date only one study (Segal et al., 2003) has been 
published in the area of resistance exercise and ADT treated men for prostate cancer. 
The study by Segal and colleagues (2003) indicated positive effects in terms of 
decreased levels of fatigue and increased quality of life, however specific physical, 
functional and physiological outcomes were not determined in their 12-week study. 
Therefore, the primary aim of experiment 2 was to extend these findings by 
examining as the effects of resistance exercise on muscle function, function 
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performance, balance, body composition, muscle thickness and hemoglobin levels in 
ADT treated men. As such, we conducted a non-randomized clinical trial where 91 
potential subjects were initially screened with 11 subjects meeting the criteria to 
entry the study and 10 subjects completing 40 exercise sessions and study measures 
during the course of six months. As presented in chapter 5, the results indicated that 
resistance exercise has beneficial effects on muscle function, functional performance 
and balance in older men receiving ADT for prostate cancer. Further, body 
composition was preserved during the 6-month intervention period and quadriceps 
muscle thickness was increased. These findings extend those reported by Segal et al. 
(2003) that found an increased quality of life and decreased fatigue in men on ADT 
following 12 weeks resistance training, and provides a rationale for why these 
benefits were observed. Moreover, our findings indicate that high intensity resistance 
training can be safety implemented as part as adjuvant therapy for prostate cancer 
patients on ADT as markers of the disease (PSA) and the therapy goal of testosterone 
suppression were unaltered during intervention. These results also support and 
extends those by Segal and colleagues (2003) who found that PSA and testosterone 
did not change following a shorter training intervention undertaken at lower intensity 
and volume.  
Although our study employed a comprehensive battery of measures to assess 
muscle and physical function, and blood markers, a randomized controlled trial 
would have been a better study design and are warranted to confirm these findings. 
However, as mentioned in Chapter 5, during the recruitment phase all men reported 
that they would not have complied with a 5-month control period if allocated to a 
control group suggesting that future exercise trials should attempt to use alternative 
control exercise groups (e.g. cardiovascular, flexibility) as a strategy to enhance 
long-term exercise compliance. Importantly, because we had rigorous inclusion 
criteria including all participants already on ADT, different to the study by Segal et 
al. (2003) where subjects were on ADT or were scheduled to initiate ADT for 12 
weeks, we are certain that this affected our sample number. Nevertheless, this 
criterion used ensured that all participants in the study were on ADT at least 2 
months before initiating training. This fact not just extends the findings of Segal et 
al. (2003) but makes our study unique in the way that all men were on least two 
months on ADT treated prior to baseline measures. In addition, we noted that 
intermittent regimens of ADT (Bhandari, Crook, & Hussain, 2005) are being 
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extensively used in major hospitals in the city of Perth, where recruitment was 
undertaken. Thus, in this specific regimen of therapy patients go “on” and “off” 
therapy, and most of the time the “on” therapy phase was insufficient to fit with our 
20-week exercise intervention and the time for all measures undertaken (6 months 
study duration) affecting our recruitment.  
Future studies are required including multi-site interventions involving 
behavioural oncology groups committed to conducting behavioural interventions to 
assist recruitment of larger study groups would be highly desirable. Further, longer 
exercise periods (>5 months) and training during intermittent regimens of ADT are 
yet to be examined. Lastly, a requirement for studies examining the impact of 
different exercise modes, intensities and dosages of training in prostate cancer 
patients undergoing different treatments and stages of the disease are yet to be 
determined and should be considered in future clinical trials. 
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APPENDIX I - RESISTANCE EXERCISE IN MEN RECEIVING 
ADT FOR PROSTATE CANCER 
 
 
1. I have read and understood the ‘Information Sheet’ for this study. 
2. The nature and possible effects of the study have been explained to me. 
3. I understand that the study involves the following procedures: 
a. I will be required to obtain my doctors approval to undertake the study before 
any measures or training can take place. 
b. I will be required to either immediately undertake a resistance training 
program for 20 weeks or to be part of a delay exercise group that will 
undertake the exercise program after the first 20 weeks of intervention. 
c. I will be required to have my height, weight, body composition, blood 
analysis (PSA, hormones, immune system assessment) muscle thickness and 
bone density taken before, at week 10 and after the study. 
d. I will be required to complete a medical history before the training program 
commences and a quality of life and fatigue and demographic questionnaire 
both before and after the training/non-training period. 
e. I understand that my muscle strength will be assessed before, during and after 
the training period. 
f. I understand that the following measures of physical function: the time to 
climb a flight of stairs, the time it takes to walk backwards 6 meters, the time 
it takes to rise from a chair and to walk 400 meters and my balance ability 
will be assessed before and after 10 and the 20-week training/non-training 
period. 
4 I understand that all research data will be treated as confidential. 
5 Any questions that I have asked have been answered to my satisfaction. 
6 I agree to participate in this study and understand that I can withdraw at any 
time without prejudice. 
7 I agree that research data gathered for the study may be published provided 
that I cannot be identified as a subject. 
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This study has been approved by Human Research Ethics Committee at Edith Cowan 
University contact number, should there be any concerns relating to the project, is 
(08) 6304 2170 or Email: research.ethics@ecu.edu.au. 
Name of subject (please Print) 
______________________________________________ 
Signed ______________________________Date ___________________ 
Contact Phone Number 
____________________________________________________ 
 
Witness (Name, please print) 
________________________________________________ 
Signed _______________________________Date ___________________ 
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APPENDIX II - MEDICAL DOCTOR CONSENT FORM 
 
Medical Doctor Consent Form for Resistance Training Study 
“Resistance Exercise in Men Receiving ADT for Prostate Cancer” 
Researchers:    Mr. Daniel Galvão, MSc, E-mail: d.galvao@ecu.edu.au   Phone:  
 
   Professor Robert Newton, PhD         E-mail: r.newton@ecu.edu.au  
  Professor Linda Kristjanson, PhD     E-mail: l.kristjanson@ecu.edu.au  
  Dr. Michael McGuigan, PhD            E-mail: m.mcguigan@ecu.edu.au   
  Dr. Nigel Spry, MBBS, Radiation Oncologist  
 
School of Biomedical and Sports Science, Edith Cowan University 
 
Dear Doctor, 
The School of Biomedical and Sports Science, Edith Cowan University is 
undertaking a study into the effects of the dosage of resistance training in older 
adults undertaking ADT (Androgen Deprivation Therapy) for prostate cancer. The 
intervention program will run for 20 weeks, entailing high-intensity progressive 
resistance (strength/weight) training for both the upper and lower body. Resistance 
training has been shown to be a safe and effective method for enhancing muscle 
strength in older adults, including the very old (JAMA, 263(22), 1990). Recently, 
Segal and colleagues (J Clin Oncol, 21(9), 2003) reported positive physiological and 
psychological benefits from this exercise modality in prostate cancer patients 
undertaking ADT. We require sixty prostate cancer patients with at least 8 weeks 
past initiation of ADT with non-bone metastases and no musculo-skeletal or 
cardiovascular disorder that could inhibit them from exercising. Participants will be 
randomly assigned to one of three groups: (1) low dosage group (1-2 sets of 4-12 
repetitions at approximately 60 to 85 % of their maximal strength); (2) high dosage 
group (2-4 sets of 4-12 repetitions at approximately 60 to 85 % of their maximal 
strength); and (3) a delay exercise group, who will undertake testing but not 
participate in training program during the first 20 weeks period. The exercise and 
major muscles used in the intervention will be: 
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1. Chest Press: Pectorals, Deltoid, Triceps Brachii  
2. Seated Rows: Rhomboids, Latisimus Dorsi, Biceps Brachii 
3. Biceps curl: Biceps Brachii, Brachialis 
4. Triceps extension: Triceps Brachii 
5. Leg Press: Quadriceps, Gluteals, Hamstrings 
6. Squat machine: Quadriceps, Gluteals, Hamstrings 
7. Leg Curls: Hamstrings 
8. Leg Extensions: Quadriceps 
 
Exercise sessions will commence with a 10-minute warm-up of aerobic activity and 
stretching and conclude with a 10-minute cool-down period that includes exercises 
for the abdominal (e.g. abdominal curls) and lower back area (e.g. single leg raises) 
and stretching. The exercise sessions will be undertaken in the Conditioning 
Laboratory in School of Biomedical and Sports Science, Edith Cowan University 
using hydraulic and traditional resistance training machines to ensure participant 
safety.  All sessions will be conducted in small groups of up to 6 participants under 
direct supervision by the principal investigators to ensure proper technique and 
minimize the risk for injury.  The total time to complete the exercise session will be 
less than 60 minutes.  
Outcome measures in the study include muscle strength and endurance, body 
composition, muscle thickness (non-invasive ultrasound) hip and spine bone density, 
endocrine responses, immunological responses, PSA levels and functional abilities 
(e.g. 400-metre walk, balance test, time to rise from a chair), all standard measures in 
studies of older adults.   
Participants must meet the following criteria to participate: (Please, check boxes if 
applied) 
1) Undertaking ADT for at least 8 weeks:  
2) Non-bone metastases:  
3) No musculo-skeletal or cardiovascular disorder that could inhibit them from 
exercising:  
The study has been approved by Human Research Ethics Committee at Edith Cowan 
University subjects will be free to withdraw from the study at any time. 
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The concern of the principle investigators are of past and/or present medical 
conditions that may compromise the individual’s ability to participate in the 
intervention, whether they be musculo-skeletal, neurological, cardiovascular, etc. in 
origin. For these reasons all potential participants have been asked to seek their 
medical doctor approval prior to involvement in the study.  
Should you require further information, please feel free to contact us by phone or by 
e-mail. 
 
 
Sincerely, 
 
Daniel Galvão and Robert Newton 
 
_____________________________is in sufficient health to participate in the above 
intervention study. 
(Participant) 
 
___________________________________________________________________ 
 (Doctor’s signature)       (Date) 
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APPENDIX III - SUMMARY PARTICIPANTS INFORMATION 
SHEET 
Resistance Exercise Dosage in Men Receiving ADT for 
Prostate Cancer 
 
Researchers: Mr. Daniel Galvão, MSc                  E-mail: d.galvao@ecu.edu.au    
    Professor Robert Newton, PhD        E-mail: r.newton@ecu.edu.au  
   Professor Linda Kristjanson, PhD    E-mail: l.kristjanson@ecu.edu.au  
   Dr. Michael McGuigan, PhD            E-mail: m.mcguigan@ecu.edu.au 
   Dr. Nigel Spry, MBBS, Radiation Oncologist 
Contact Telephone number:  
             
 
School of Biomedical and Sports Science, Edith Cowan University 
Participant Information Sheet  
SUMMARY  
Purpose of the Study: To examine the effects of resistance training or weight 
training on weight gain, loss of muscle and bone mass, tiredness, immune system and 
quality of life in men with prostate cancer. 
Subject Involvement: We require 60 prostate cancer patients undertaking treatment 
to suppress male hormones to participate in this 20-week exercise study. Individuals 
will be required to have non-bone metastases and no musculo-skeletal or 
cardiovascular disorder that could prevent them from exercising, and not to have 
participated in any weight training in the previous 12 months. In addition, volunteers 
will be required to obtain consent from their doctor before participating in the study.   
Intervention: Participants will be placed in one of two groups (by chance): immediate 
exercise or delayed exercise group. Training groups will undertake twice weekly 
supervised training sessions for 20 weeks. The delayed exercise group will 
participate in the tests, and receive all information resulting from them, but not 
exercise during the first 20 weeks of the intervention. A subsequent training program 
will be provided for the delayed exercise group.  
                                                      Resistance Training in Men Receiving ADT     
 
 119
Test Measures: Before starting the training, after 10 and 20 weeks participants will 
be asked to take part in some tests to measure their strength, muscle characteristics 
and abilities to take part in activities (i.e. rise from chair, walk 400 meters). Also 
samples of blood will be obtained to assess relevant characteristics. In addition, 
participants will be asked to complete some brief questionnaires about their quality 
of life and abilities to take part in activities of daily living.   
PARTICIPATION IS VOLUNTARY AND SUBJECTS ARE FREE TO WITHDRAW 
FROM THIS STUDY AT ANY TIME. 
The study has been approved by Human Research Ethics Committee at Edith Cowan 
University subjects will be free to withdraw from the study at any time. Contact 
number, should there be any concerns relating to the project, is (08) 6304 2170 or 
Email: research.ethics@ecu.edu.au. 
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APPENDIX IV - PARTICIPANT INFORMATION SHEET 
Resistance Exercise Dosage in Men Receiving ADT for 
Prostate Cancer 
 
Researchers: Mr. Daniel Galvão, MSc                  E-mail: d.galvao@ecu.edu.au    
    Professor Robert Newton, PhD        E-mail: r.newton@ecu.edu.au  
   Professor Linda Kristjanson, PhD    E-mail: l.kristjanson@ecu.edu.au  
   Dr. Michael McGuigan, PhD            E-mail: m.mcguigan@ecu.edu.au 
   Dr. Nigel Spry, MBBS, Radiation Oncologist 
 
Contact Telephone number: Daniel Galvão  
        
School of Biomedical and Sports Science, Edith Cowan University 
Participant Information Sheet 
Purpose of the Study 
The usual treatments for prostate cancer may have side effects. Some of these side 
effects include weight gain, loss of muscle and bone mass, tiredness which may 
affect a person’s quality of life. However, exercise has been shown to be a safe and 
effective method for strength development in older adults. Recently, resistance 
exercise has also been shown to safely increase muscle strength, quality of life and 
decrease tiredness in men with prostate cancer. However, the effect of resistance 
exercise on weight gain, muscle and bone mass and the immune system in this cancer 
group is unknown. Therefore, the purpose of this present study is to examine the 
effects of resistance training on weight gain, loss of muscle and bone mass, tiredness, 
immune system and quality of life in men with prostate cancer. The findings from 
this study will allow health professionals to plan exercise and the correct amount of 
exercise for men with prostate cancer to help decrease side effects and improve their 
quality of life 
Subject Involvement 
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We require 60 prostate cancer patients undertaking treatment to suppress male 
hormones for at least six weeks to participate in this 20-week exercise study. 
Individuals will be required to have non-bone metastases and no musculo-skeletal or 
cardiovascular disorder that could inhibit them from exercising, and not to have 
participated in any weight training in the previous 12 months. In addition, volunteers 
will be required to obtain consent from their doctor before participating in the study.   
In study 1, participants will be randomly allocated (by chance) to one of two groups: 
immediate exercise or delay exercise group. In study 2, subjects from the immediate 
exercise group (study 1) will be randomly allocated to two different training 
protocols: low or traditional training dosage while the delay exercise group will 
remain in a non-exercise condition. Training groups will undertake twice weekly 
training for 10 weeks (study 1) with subsequent 10 more weeks (study 2) comprising 
20 weeks of intervention. The delay exercise group will participate in the tests, and 
receive all information resulting from them, but not exercise during the first 20 
weeks of the intervention. A subsequent training program based from the outcome 
measures from the first 20 weeks will be provided for the delay exercise group.  
Training protocol  
Twice weekly exercise sessions will commence with a 10-minute warm-up 
comprising of low-level activity such as walking and stationary cycling, as well as 
stretching. 
Eight exercises that target the major upper and lower body muscle groups will be 
performed using hydraulic resistance machines during the first 10 weeks of training 
(Study 1).The exercises are: Chest Press/Seated Row, Biceps curl/Triceps extension, 
Leg Press, Shoulder press/ Lat pull down, Squats, Leg Extension/Leg Curls, Upper 
rower/ Dips, Abdominal/ Back extension. 
Ten exercises that target the major upper and lower body muscle groups will be 
performed using traditional resistance machines in the last 10 weeks of training 
(study 2). The exercises are: Chest Press, Seated Row, Biceps curl, Triceps 
extension, Leg Press, Shoulder press, Lat pull down, Leg Extension, Leg Curls, and 
Abdominal. 
Exercise sessions will conclude with a 10-minute cool-down that includes exercises 
for the abdominal and lower back area and stretching. The exercise sessions will take 
place in the Strength and Conditioning Laboratory, School of Biomedical and Sports 
Science, at Edith Cowan University, using hydraulic weight training machines (study 
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1) and traditional weight training machines (study 2) to ensure participants safety. 
All sessions will be conducted in small groups of up to 6-8 participants under direct 
supervision by the principal investigator to ensure proper technique and minimize the 
risk for injury. The total time to complete the exercise session is less than 60 
minutes. All participants will be asked to maintain customary physical activity and 
dietary patterns over the 20-week period. 
The resistance will be set progressively from 12 to 4 repetitions maximum (RM) 
using repeated lifts before having a rest period. In study 1, the exercise group will 
perform 2-4 sets of 4-12RM. In study 2, the low dosage training group will perform 
only 1-2 sets of 4-12RM while the traditional training dosage group will perform 3-5 
sets of 4-12RM for each exercise. 
To ensure the progressive nature of the training program, both training groups will be 
encouraged to work past a specific number of repetition-mark.  When subjects are 
able to perform more than the number of repetitions required, during a set the 
workload will be increased by a 5 - 10% increment for the next set or training 
session.  
 
All training will take place on Monday and Thursday or Tuesday and Friday. 
Test Measures 
Prior to the commencement of training, after 10 and 20 weeks a series of tests will be 
administered.  The delay exercise group will only undertake the testing measures 
before and after the first 20 weeks of intervention and then at 10 and 20 weeks of 
their exercise intervention.   
Body composition and bone density 
• Body composition (fat mass and lean mass) and bone density of the hip and 
spine sites will be measured by dual x-ray absorptiometry (DXA), a routine 
technique for the measurement of bone density.  You will lie on a specially designed 
table for approximately 10 minutes and a scanning arm will move above your total 
body and above your hip and spine (separate scans for your whole body, hip and 
spine).  A low-dosage x-ray will pass from underneath the table to the scanning arm.  
The total radiation dose for all scans undertaken during the study is very low only a 
little more than normal background radiation and much less than, for example, an 
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international flight. Note: height and hip/spine density will not be measured at 6 
weeks, only before at week 10 and following the 20-week intervention period. 
Muscle thickness 
•    Muscle thickness of the elbow and knee flexors and extensors will be measured 
by ultrasound images; this is a safe and non-invasive method to assess soft 
tissues. The scanning probe will be coated with a water-soluble transmission gel 
to provide acoustic contact to the surface and some ultrasound images will be 
recorded from the muscles to determine thickness of the muscles. It will take 
about 5 minutes to obtain all images, the images will be taken when you sit on a 
chair or stand. All the testing will take place in the Exercise Physiology Research 
Laboratory in building 19 on the Joondalup Campus.  
PSA, Hormones, Immune system, Bone markers and Beta amyloid (Aβ) 
• PSA, Hormones, Immune system markers, Bone markers and Aβ will be 
determine from blood samples to assess any changes in these physiological 
markers. All the testing will take place in the Exercise Physiology Research 
Laboratory in building 19 on the Joondalup Campus. 
Muscle performance 
• Maximal muscle strength will be determined for each of the several upper and 
lower body muscle exercises to be undertaken in the training program using 
weight-training machines. The maximal strength is the most weight that can be 
lifted one time using correct technique. This test will also be performed at week 6 
and 18 for the immediate exercise group.   
• To determine muscle endurance of the upper and lower body, the number of 
times you can lift a weight that is 70% of your 1RM will be determined.   
Functional performance (only undertaken before at week 10 and after the 20-week 
period) 
• Stair climb 
You will be asked to ascend a flight of stairs (11 stairs) as fast as possible.   
• 6-meter backwards walk 
As a test of balance, participants will place one foot will behind the other and will 
be asked to walk backwards 6 meters.   
• Chair rise   
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You will be seated in a chair and asked to rise and sit 5 consecutive times, 
without the use of your arms for support, as fast as possible. 
• 400-meter corridor walk 
You will be asked to walk 20 meters in a corridor, turn and return to the starting 
position and repeat another 9 times.  
• Balance test 
You will be asked to stand on a special platform under conditions of eyes open 
and eyes closed.  The platform will tilt slightly back and forth and the 
surrounding walls will also move.  You will be wearing a harness which will 
support your body weight if you lose balance. 
Before muscle performance and physical function tests are performed, 
demonstrations, practice time, sufficient warm-up and stretching will be undertaken. 
 
Lifestyle questionnaires (only undertaken before and after the 20-week period) 
• Quality of life will be assessed using a standardized questionnaire (Functional 
Assessment of Cancer Therapy-Prostate, FACT-P) as well as Levels of Fatigue 
(Functional Assessment of Cancer Therapy-anemia, FACT-an) that you can 
complete at home.   
• Health history and Demographic information will be also assessed using 
standardized questionnaires that you can complete at home 
 
Risks 
Resistance training may result in mild discomfort and muscle soreness, however, this 
will be minimised by all sessions being supervised and commencing with a warm-up 
and concluding with a cool-down period of mild stretching activities. It is also 
possible that some muscle soreness may result from baseline performance testing, 
however, all participants will undertake a warm-up period of stretching before 
beginning the full exercise program. The risk of discomfort and muscle soreness will 
also be minimised by a gradual increase in exercise intensity. Lastly, risk of falling 
may exist in the performance of some tasks, however, participants will be closely 
supervised and spotted to prevent a fall from occurring. In the event that an 
emergency occurs, medical assistance will be obtained from the University Health 
Service according to our established emergency procedures. Lastly, the discomforts 
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associated with the blood drawing procedures are minimal. There is a risk that 
sometimes bruising and infection may occur and that the arm might become sore.  
Risk of bruising or infection from the blood draws will be minimized because all 
blood draws will be performed by a trained phlebotomist (lab technician) with 
extensive experience in both research and clinical settings. The total amount of blood 
drawn during each testing session will not exceed 10 ml. No syringes, lancets, 
needles or other devices capable of transmitting infection from one person to another 
shall be reused.  All of these items, which are disposable, will be destroyed after each 
use.  As an additional safeguard in preventing contamination new disposable gloves 
will be required for all blood draws.  All contaminated items will be disposed of 
promptly in sharps containers 
 
All information will be strictly confidential and kept safely locked in a filling cabinet 
in the primary investigators office. Should publications result from this study, no 
reference will be made to any individuals.  
 
On completion of the intervention and measurements, a summary of study and 
individual results will be made available to all participants.  
 
PARTICIPATION IS VOLUNTARY AND SUBJECTS ARE FREE TO 
WITHDRAW FROM THIS STUDY AT ANY TIME. 
The study has been approved by Human Research Ethics Committee at Edith Cowan 
University subjects will be free to withdraw from the study at any time. Contact 
number, should there be any concerns relating to the project, is (08) 6304 2170 or 
Email: research.ethics@ecu.edu.au. 
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APPENDIX V - EXAMPLE OF UPPER AND LOWER BODY 
EXERCISES USING THE HYDRAULIC RESISTANCE 
EXERCISE EQUIPMENT 
(Prostate Cancer Study) 
 
Shoulder press/Lat pull down exercise 
 
 
 
 
Leg extension/ leg curl exercise 
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Biceps curl/ triceps extension 
 
Chest press/ seated row 
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APPENDIX VI - LETTER TO THE PARTICIPANT 
 
Thank you for your interest in the study “Resistance Exercise in Men Receiving 
Androgen Deprivation Therapy for Prostate Cancer.” 
 
Please find attached: 
 
1. A “Participant Information Sheet” outlining all aspects of the study; 
2. A “Summary of Participants Information Sheet”; 
3. A “Statement of Informed Consent” which you will be required to sign before 
participating in the study; 
4. A “Medical Doctor Consent Form” for your doctor;  
5. A sheet titled “Hydraulic Resistance Training Exercises” which contains 
photographic depictions of several exercises to be undertaken in the study; 
and 
6. A map of the Joondalup Campus. 
 
As previously mentioned, all volunteers are required to obtain their doctor’s approval 
prior to participation – please take the Medical Doctor form and the resistance 
training exercises sheet to your doctor (GP) and have them complete and sign the 
consent form (you may also want to show them the Participant Information sheet). 
Following approval from your doctor, please contact me to arrange a meeting where 
an orientation to the study will be provided and baseline measurements will 
commence. At this meeting, please bring with you the “Medical Doctor Consent 
Form” and “Statement of Informed Consent.” 
 
If you have any questions, please don’t hesitate to contact me. 
 
I look forward to hearing from you. 
 
Best regards, 
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Daniel Galvão MSc (PhD Candidate) 
Ph:  Email: d.galvao@ecu.edu.au 
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APPENDIX VII - HEALTH HISTORY QUESTIONNAIRE 
 
Resistance training in men receiving androgen deprivation therapy for 
prostate cancer 
 
Medical History and Medications Questionnaire 
 
___________________________________________________________________ 
Last Name                                      First Name                  Middle                  Initial  
 
____________________________________________________________________ 
Date of Birth (Age)                            Sex                                              Home Phone 
 
___________________________________________________________________ 
Address                                             City, state                                  Post code 
 
___________________________________________________________________ 
Family Physician      
 
Emergency Contact (Name)                        Phone                                Relationship 
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MEDICAL HISTORY 
GENERAL 
1) Smoking 
(a) Are you or have you ever been a smoker?   Yes / No.     
(b) Past / Current smoker?  
(c) Age you started smoking:  
(d) Age you quit smoking (for past smokers only):  
(e) Average number of cigarettes smoked per day:  
 
2) Drinking (alcohol)  
(a) How many drinks do you usually have per week?  
 
3) Body weight 
(a) Has your weight fluctuated more than a few kilos in the last 12 months? Yes / 
No.    
(b) If ‘Yes’, approximately how many kilograms? 
 
4) Physical activity  
(a) What is your current level of physical activity? Active/ Inactive. Details: 
____________________________________________________________________ 
____________________________________________________________________ 
____________________________________________________________________ 
____________________________________________________________________ 
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5) Medical condition 
(a) When have you been diagnostic with prostate cancer? 
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________ 
(b) Which types of treatments have you undertaken (or are currently undertaking), 
example: Androgen deprivation therapy, radiation therapy, systematic therapy 
and/ or surgical castration? Please, specify the duration of treatment? 
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________ 
____________________________________________________________________ 
 
(c) Do you know your PSA levels? When it was the last time that your PSA levels 
were assessed?  
____________________________________________________________________
____________________________________________________________________ 
 
(d) Do you have any other medical conditions? (chronic or serious illness) Yes /No. 
Details: 
____________________________________________________________________ 
____________________________________________________________________ 
____________________________________________________________________ 
____________________________________________________________________ 
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____________________________________________________________________ 
 
(b) Have you ever had any medical surgery? Yes /No.  Details: 
____________________________________________________________________ 
____________________________________________________________________ 
____________________________________________________________________ 
____________________________________________________________________ 
____________________________________________________________________ 
 
6) Bones 
(a) Have you been tested for osteoporosis before (DXA scan)?  Yes / No 
(b) What were the results?   Normal bone density / Osteopenia / Osteoporosis 
(c) Have you been placed on any medications to help strengthen your bones?  
(i.e Fosamax, Actonel, Calcitriol)  Yes / No    (Include details of medications in 
Medications Questionnaire.) :_________________ 
(d) Has your doctor recommended you do anything else to improve your bone 
density?  (i.e. weight bearing exercise, calcium supplements)   Yes /No. Details:  
____________________________________________________________________ 
____________________________________________________________________ 
____________________________________________________________________ 
____________________________________________________________________ 
 
(e) Have you ever broken a bone as a result of minor trauma? (including vertebral 
crush fractures)  Yes / No. Details: 
____________________________________________________________________ 
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____________________________________________________________________ 
AT THE PRESENT 
 
(a) Do you experience shortness of breath while walking with others of your age?  
Yes / No 
Do you experience sudden tingling, numbness, or loss of feeling in arms, hands, legs, 
feet, or face? 
Yes / No 
 
(b) Do you experience swelling of your feet and ankles?  
                  Yes / No 
 
(d) Do you get pains or cramps in your legs? 
                  Yes / No 
 
(e) Do you experience any discomfort in your chest?  
                 Yes / No 
 
(f) Have you ever been told that your blood pressure was abnormal? (If yes, do you 
currently take any medication?) 
               Yes / No 
 
(g) Have you ever been told that your serum cholesterol or triglyceride level was 
high? 
               Yes / No 
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(h) Do you have diabetes? (If yes, how is controlled?)  
Yes / No. Details: 
____________________________________________________________________ 
____________________________________________________________________ 
____________________________________________________________________ 
 
MEDICATIONS 
 
Please list below medications you are currently taking. Fill out every column for 
each medication you list.  
 
MEDICATION 
 
DURATION
(in months 
and years) 
Reason for taking (which medical condition) 
and other comments 
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APPENDIX VIII - DEMOGRAPHIC QUESTIONNAIRE 
 
Resistance training in men receiving androgen deprivation therapy for 
prostate cancer 
 
Demographic Questionnaire 
To assist us with our research, we would like to know a little about your background.  
Please circle your response to each of the questions below.   
 
1. How old are you?     __________ years,    or circle the correct age group  
 
 20-30yrs 31-40yrs 41-50yrs 51-60yrs 61-70yrs 71-80yrs     
>80  
 
2. What is your current marital status? 
 
Single Married  Defacto     Separated   Divorced   Widowed 
 
3. What is the highest level of education you completed? 
  
Primary                  Secondary                         Trade                 Certificate/Diploma      
 
 Bachelor degree   Higher degree    Other___________ 
 
4. What is your current occupation?  
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Homemaker  Clerical Computing Professional      Management    
 
Labourer Trade   Retired     Other ______________ 
  
5. What other responsibilities do you have? (Please circle as many as 
appropriate) 
 
Dependent children     Elderly relatives       Care of sick/disabled relatives  
 
Study      Community volunteering No responsibilities  Other __________ 
 
6. In which country were you born? 
 
Australia   UK   Asia   Europe   America    South America Africa     
Other__________ 
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APPENDIX IX – ETHICS APPLICATION 
 is not included in this version of the thesis
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APPENDIX X - HYDRAULIC RESISTANCE TRAINING LOG 
 
Name: ____________________________________________ 
 
Date 
(sessions #) 
 
(1) 
 
(2) 
 
(3) 
SETS 
 
1 2 3 4 1 2 3 4 1 2 3 4 
Chest press 
Seated Row 
            
Leg press             
Shoulder p. 
Lat pull 
            
Squat             
Upper row 
dips 
            
Leg extens. 
Leg curl 
            
Biceps curl 
Triceps ext. 
            
Abs 
Back ext. 
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APPENDIX XI - ISOTONIC RESISTANCE TRAINING LOG 
Name: ____________________________________________ 
 
Date 
(sessions #) 
 
(1) 
 
(2) 
 
(3) 
SETS 
 
1 2 3 4 1 2 3 4 1 2 3 4 
Chest press 
 
            
Leg press 
            
Lat pull             
Squat             
Leg 
extension 
            
Shoulder 
press 
            
Leg curl 
            
Triceps ext.             
Biceps curl 
 
            
Abdominal              
 
